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ABSTRACT

Exploring early signaling associated with complex stressors
Julia A. Penatzer

Humans are constantly exposed to a vast number of stressors in our everyday lives from social
interactions to physical activity to chemical exposures, to name a few. These stressors have
significant impacts on an individual, from the cellular to whole organismal level. The body
contains an intricate communication system that elicits a number of both biological and
physiological responses as it attempts to maintain homeostasis. Observing these responses to
stressors, can offer insight into a number of outcomes, which can be beneficial (increasing life
longevity) or detrimental (leading to a disease state). By measuring specific biological adaptations
at particular time points, we can better understand the organismal response to these stressors.
While human studies provide a unique opportunity to truly understand the organismal response,
there are a number of factors that influence individual responses. Therefore, replicating these
stressors in vivo can be exceptionally difficult, especially when the primary focus of many studies
is on a single stressor, rather than a more realistic combinatory exposure. The work presented in
this dissertation had the ultimate goal of building upon previous research with a focus on the
biochemical adaptations that take place to protect and maintain optimal organismal function.
Specifically, this dissertation observes both extracellular (cytokine) and intracellular
(phosphorylation modifications) responses to social, physical, and occupational stressors.
Additionally, this work observes both systemic and localized responses in different biological
samples (saliva vs ex vivo tissue) to analyze various biomarkers of stress. The findings from this
dissertation reveal the rapid responses of signaling mechanisms related to complex mixtures in
both human and animal work.
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Chapter 1: Introduction to stress and stressors and the measurable biological and
physiological responses
Humans are constantly exposed to stressors, including biological, chemical, and
physiological stimuli as well as mental and social situations on a daily basis. Stressors broadly
represent a “threat” to organismal homeostasis, which initiates a complex stress response within
the body that is integral to adapting to the stressor [1]. This response relies on communication
between the brain and body through the nervous, endocrine, and immune systems [2-3], which
release biochemical messengers to promote adaptation [4]. The regulation of these biological
responses occurs through a number of feedback loops to maintain homeostasis, where positive
feedback generally refers to the amplification of the response and negative feedback inhibits the
response.
It is important to note all of the potential factors that influence the organismal response.
Both internal stressors, specifically those that originate from the organism, including genetics,
nutrition, and lifestyle choices, and external stressors, stimulants imposed on the organism,
encompassing stressors such as occupational exposures, air pollution, socioeconomic status, and
social relationships, can impact how an individual will respond to the stressor. Additionally, as
commonly termed in toxicology with any exposure, “it is the dose that makes the poison”, wherein
the duration, frequency, and degree of the stressors will affect the overall organismal response.
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Figure 1.1. Factors influencing the response to stressors. Various stressors (physical, social, chemical) activate the
nervous, endocrine, and immune systems to initiate a biological response. This response is based on the intensity and
duration of the exposure. Both internal and external factors influence how an individual will respond to the stressors.
Stress responses can be either positive or negative.

1.1 Definition of stress
In 1936, Hans Selye, the father of modern stress research, first wrote about the biological
formulations of stress [6]; stress was used as a descriptive term to explain “the nonspecific
response of the body to any demand” [7-8]. In his work, Selye suggested two terms to explain
different types of stress: eustress (positive stress) and distress (negative stress) [9]. However, the
modern-day term “stress” has taken on the negative connotation as this version has been the focus
of numerous studies. According to Bienertova-Vasku et al. (2020), the term distress is used nearly
80 times more than eustress in scientific literature [10]. While too much stress is certainly
2

detrimental and can lead to a variety of disease states, there is a critical point at which stress can
produce positive results [11-13]. It is also important to be mindful of hormesis, in which moderate
exposures can improve functionality and/or tolerance to more severe stimuli, but high doses result
in toxicity. Thus, it is critical to appropriately model realistic exposures (e.g., physical, chemical,
environmental, social situations, etc.) to fully understand the organismal response.
1.1.1 Social stressors
Humans, as an inherently social species, experience both negative and competitive social
interactions daily [14-16]. Social interactions start at birth and continue through the remainder of
our lives as these connections are necessary for survival [17]. Basic threats to these interactions
(e.g., rejection, isolation, conflict, or loss) signal to our body that one is more vulnerable and may
face a greater likelihood of wounding and infection, initiating a biological response [18].
Additional research has expanded upon this displaying how social situations such as public
speaking, mental arithmetic, and anticipation, as well as emotional states created by social ties,
such as anxiety, anger, and depression further increase the biological response [19-24]. Therefore,
as social stress is a critical component of our everyday lives, it is important to observe how social
experiences, including those experienced in certain occupations, can influence our biological
response.
1.1.2 Occupational stressors
Some individuals also experience occupational-related stressors, such as occupational
hazards (e.g., exposures to chemical, biological, and physical factors), on a daily basis. These
hazards are a common health risk for a variety of professions (e.g., health care workers,
construction workers, military, farmers, etc.) that can lead to a range of diseases, including chronic
obstructive pulmonary disease, cardiovascular disease, and cancer [25-26]. In fact, approximately
3

one quarter of all deaths globally are related to working in unhealthy environments with chemical
hazards being the leading causative risk factor [27-28].
One particular occupation that is at an increased risk to a number of stressors is the military.
Both external exposures (i.e., chemical, biological exposures) and internal, cognitive-based
stressors (i.e., traumatic events, information overload) are intricately intertwined into stressors that
the military personnel are at risk too while deployed [29]. More importantly, military personnel
are often exposed to high dose, acute expedient exposures, while most other occupations would
consider this high risk and are more often only exposed to low doses [30].
Organophosphates (OPs) represent one such category of chemical exposures that military
personnel can be exposed to during deployment because of the risk of its use as a pesticide and
chemical warfare agent [31]. OPs have a similar structure and thus mechanism of action; they bind
to acetylcholinesterase (AChE) at the active serine site, which results in cholinergic toxicity due
to the persistent stimulation of the cholinergic receptors [32]. Mild exposures can result in
headaches, blurry vision, salivation, and muscle weakness, but continued high-level exposure can
lead to difficulty breathing, convulsions, irregular heartbeats, and eventually coma or death [33].
Each year there is an estimated 3 million people exposed to OPs worldwide which results in
approximately 300,000 deaths [34]. Individuals who survive acute high-level exposure to OPs
have extended symptomology associated with eye fatigue, blurred vision, body fatigue,
headaches/dizziness, and cognition problems (forgetfulness) [35-36]. In fact, exposure to OP
insecticide and nerve agent-OPs have been implicated in a specific military disease state, Gulf War
Illness (GWI).
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1.1.2.1 Gulf War Illness
Nearly 200,000 soldiers who served during the 1990-91 Persian Gulf War (GW) returned
home from deployment with a variety of chronic, unexplained symptoms that was eventually
referred to as GWI [37]. Today, these GW veterans continue to suffer from a multitude of medical
symptoms, including cognitive and memory impairments, depression, and gastrointestinal
disorders [38-41]. The exact etiology of GWI remains unknown, but the Research Advisory
Committee on Gulf War Veterans’ Illnesses concluded that exposure to AChE inhibitors,
specifically OPs such as sarin [42] or pesticides were the most likely cause of the symptoms of
GWI [43-44].
1.2 The biological and physiological responses to stressors
In an effort to better understand the localized and systemic responses to these various
stressors (e.g., social and occupational stressors), it is important to understand the fundamentals
driving the basic biological responses. Once an exposure occurs, the “fight or flight response” is
initiated, which regulates the simultaneous activation of a number of biological and physiological.
The most heavily studied stress-related systems are the sympathetic nervous system (SNS) and the
hypothalamic-pituitary-adrenal (HPA) axis for the nervous and endocrine systems, respectively
[45]. Once activated by a stressor, the SNS and HPA axis work cooperatively to coordinate an
appropriate response that can be initiated within seconds, but might last for days to restore
homeostasis. A brief overview of the role of these systems will be covered below.
1.2.1 The nervous system response
The autonomic nervous system, which regulates the body’s involuntary actions (breathing,
heart rate, blood flow, digestion, etc.) is divided into the SNS and the parasympathetic nervous
system (PNS). The PNS is responsible for activities when the body is at rest (e.g., digestion,
5

urination, sexual arousal), while the SNS primarily stimulates the body’s fight or flight response.
Once activated by a stressor, catecholamines, the amine derivatives of catechol that include
epinephrine and norepinephrine, are secreted from the adrenal medulla and sympathetic nerves
[46]. The catecholamines are then released into the bloodstream which helps increase blood flow
to essential organs, such as the skeletal muscle, brain, and heart, to provide an immediate reaction
to a stressor [47]. Binding of the catecholamines to β-adrenergic receptors on the cell surface
increases intracellular cyclic adenosine monophosphate (cAMP) and leads to glycogen breakdown,
providing the energy needed to mobilize the body to deal with the immediate adaptive response
[45, 48].

However, chronic activation of the SNS suppresses the immune system, causes

hypertension, and accelerates the onset of a number of cardiovascular diseases [49-51].
1.2.2 The endocrine response
Like the SNS, the HPA axis is also crucial in the organismal response to stressors, but, as
a hormonal system, activation does not occur until minutes after stimulation [52]. After activation,
neurons in the paraventricular nucleus of the hypothalamus synthesize and release corticotropinreleasing factor (CRF) and arginine vasopressin [53]. Binding of CRF stimulates the anterior
pituitary gland to produce adrenocorticotropic hormone (ACTH) and release into the body’s
circulation [54]. This initiates a cascade of events that culminate in the release of glucocorticoids
(GCs) from the adrenal cortex [55]. The main GC synthesized in the adrenal glands is cortisol in
humans (and corticosterone in rodents), which inhibits insulin production to mobilize glucose
reserves for energy [55-57]. GCs play a prominent role in regulating the magnitude and duration
of the HPA axis stimulation through a negative feedback loop; specifically, a rapid feedback
mechanism mediates inhibition of CRF and ACTH secretion [58].
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1.2.2.1 Cortisol and corticosterone
Corticosterone is the primary adrenal corticosteroid in rodents because they lack the
adrenocortical zona fasciculata enzyme 17-α hydroxylase [56]. Corticosterone is also found in the
bloodstream of primates, but 10-20 folds lower than cortisol [56, 59-61]. The majority of cortisol
(and corticosterone) is bound to corticosteroid-binding globulin and only a small fraction is
biologically active [62-64]. However, both GCs have low molecular weight (~362 Da for cortisol
and ~346 Da for corticosterone) and are lipophilic, allowing them to passively diffuse into cells,
which makes it feasible to measure free cortisol in blood [64-65]. It is important to note that both
GCs follow a circadian rhythm with levels peaking early in the morning and gradually decreasing
throughout the day [64-66] Importantly, cortisol and corticosterone play an essential role in
suppressing the immune response, specifically T cell responses [63-64].
1.2.3 The immune system
The immune system may not typically be perceived as part of the fight or flight response,
but stressful situations put an individual at an increased risk for potential injury and therefore
infection [67]. As such, studies have observed the effects of various stressors on the immune
system by measuring markers of inflammation [22, 68-69]. Inflammation, at the tissue level, can
be characterized by redness, swelling, heat, and pain that leads to the activation of the immune
response on the cellular level. Inflammation is the immune system’s response to stressors and acts
by eliminating pathogens and initiating healing [70-71]; however. chronic inflammation increases
risk for a number of diseases [72-73]. The immune system has two main responses: the adaptive
and innate immune response.
The adaptive immune response involves a slow process because of the specificity of the
pathogen, but once this defense system has been stimulated, it can provide long-lasting protection
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[67]. The adaptive immune response is carried out by B cells and T cells that involve the antibody
response and the cell-mediated immune response, respectively [74]. In the antibody response, B
cells are activated to secrete antibodies to bind to foreign antigens encountered in the bloodstream.
This directly inactivates the pathogens by preventing them from binding to receptors on host cells
[75]. In the cell-mediated immune response, T cells react against an antigen, but only to those
bound to receptors on the surface of a host cell.
The innate immune response consists of a number of cells (e.g., neutrophils, macrophages,
eosinophils) that deliver a non-specific defense, attacking a number of pathogens [67]. Moreover,
the innate response can provide a defense on a short time scale in response to stressors (minutes to
hours). Damage-associated molecular patterns (DAMPs) are released in response to injury which
promotes the release of hydrogen peroxide and recruits innate inflammatory cells [75]. When the
innate immune cells sense DAMPs, the cells start producing cytokines, which can act on the cells
that secreted them, nearby cells, or distant cells to be recruited to the site of injury to either maintain
an inflammatory response or restores homeostasis [76].
1.3 The cytokine response
Cytokines are a large group of soluble glycoproteins secreted by immune cells that play an
essential role in signaling the innate immune response. To date, hundreds of cytokines have been
identified and they play a role in nearly every biological process including inflammation, disease
pathogenesis, non-specific response to infection, and changes in cognitive functions, to name a
few [77]. Several features of cytokines may contribute to the various roles they play in the
biochemical response. For example, some cytokines have pleiotropic properties (i.e., one cytokine
exerts different types of responses on different cell types), such as interleukin (IL)-6 that influences
both the adaptive immune responses as well as inflammatory reactions [78]. Another feature some
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cytokines exhibit is functional redundancy (i.e., many cytokines can induce similar effects) [7980]. For example, IL-4 and IL-13 activate common pathways and are suggested to serve redundant
functions in vivo [81]. Cytokines can also have synergistic or antagonistic effects, allowing some
cytokines to initiate certain functions while others inhibit it.
Importantly, the cytokine response to stressors involves a delicate balance between proand anti-inflammatory cytokines. Pro-inflammatory cytokines are primarily produced by
macrophages and promote inflammation and immunity [76]. Some of the best known proinflammatory cytokines include IL-1, IL-12, interferon (IFN)- γ, and tumor necrosis factor (TNF)α [82]. Conversely, anti-inflammatory cytokines are produced to regulate the pro-inflammatory
cytokine response and are secreted from immune cells [76, 82]. IL-10, IL-4, and IL-13 are a few
of the most well-known anti-inflammatory cytokines [81]. While some of these cytokines have
been well established into these subgroups, other cytokines, such as IL-6, have both properties
under different circumstances [83]. Four cytokine classes will be briefly discussed below: ILs,
INFs, TNFs, and colony-stimulating factors (CSFs).
1.3.1 Interleukins
ILs play essential roles in activation and differentiation of immune cells and are primarily
expressed by leukocytes [84]. They consist of a large group of proteins that have both pro- and
anti-inflammatory properties and primarily modulate growth, differentiation, and activation during
immune responses. ILs have a mostly localized effect with a short circulation time that is tightly
regulated by positive and negative feedback loops to establish this delicate balance between proand anti-inflammation [85].
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1.3.2 Interferons
IFNs are proteins that were originally discovered to defend against viral infections, but
have a number of diverse functions including modulating inflammatory responses, inhibiting (or
stimulating) cell growth, inhibiting (or activating) apoptosis, and modulating multiple components
of the immune system [85]. IFNs can be broken down into two main groups: type 1 and type 2.
Type 1 comprises 13 different IFN-α isomers, IFN-β, IFN-κ, IFN-ω, and IFN-ε and are induced
by viral infections [85-86]. Type 2 IFNs, synthesized by T and natural killer cells, consist of only
one isomer, IFN-γ, which plays an essential role in the cell-mediated immune response [87]. IFN
signaling has also been linked to the Janus kinases/signal transducers and activators of
transcription (JAK/STAT) pathway, which activates a number of downstream signaling cascades
[88-89].
1.3.3 Tumor necrosis factor
TNF is produced by phagocytes, neutrophils, lymphocytes, endothelial cells, and
fibroblasts and contributes to cell survival, proliferation, differentiation, and death [90-91]. TNF
is another pleiotropic cytokine that has anticancer properties, regulates the immune system, and
protects against infections, but also stimulates proliferation and migration in cancer cells and is
linked to several genetic diseases [91-93]. Another example of TNF’s pleiotropic role involves the
activation of both nuclear factor κB (NF-κB) and c-Jun N-terminal kinase (JNK), which function
as cell survival and cell death signaling pathways, respectively [91].
1.3.4 Colony-stimulating factors
CSFs have been termed the master regulators of granulocytes and macrophages [94]. CSFs
have five major actions that include apoptosis suppression, proliferative stimulation, lineage
commitment decisions (whether a precursor cell produces granulocytic or macrophage progeny),
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initiation and regulation of maturation, and functional activity of mature granulocytes and
macrophages [94-95]. There are four distinct types of CSFs: granulocyte colony-stimulating factor,
macrophage colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GMCSF), and multipotential colony-stimulating factor (IL-3) [96]. CSFs are strictly regulated and
have a short half-life in vivo, but have been shown to significantly increase 1,000-fold within hours
after stimulation [94].
1.4 Intracellular cell signaling
While looking at the immune system provides important insights into the inflammatory
response, it is also important to note the cascade of intracellular signaling that can result. This
cascade is the primary way the cell responds to the environment when receiving extracellular
signals (e.g., hormones, xenobiotics, cytokines, etc.). As previously mentioned, immune responses
can activate distinct signaling pathways that can lead to an adaptive stress response that can result
in a return to homeostasis, cell death, or adaptation to a new diseased steady state [97].
1.4.1 G-protein coupled receptors (GPCRs)
In order for the cell to respond to changes in the environment, the cell surface receptors
must be able to receive and process signals. G-protein coupled receptors (GPCRs) are the largest
family of membrane proteins and can be divided into five subfamilies: rhodopsin, secretin,
glutamate, adhesion, and Frizzled/Taste2 [98-99]. All of the families share a common structural
motif, the seven membrane-spanning α-helical segments connected to alternating intracellular and
extracellular loops [98-99]. Binding of endogenous hormones, neurotransmitters, and
pharmacological agents to GPCRs initiate a conformational change that activates secondary
messengers [100].
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1.4.2 Secondary messengers-cAMP
Secondary messengers are produced or released through the signals from the receptor that
then propagate signals throughout the cell [101]. Secondary messengers mediate a number of
biological processes including memory, metabolism, gene regulation, and immune function [102].
cAMP is a common secondary messenger that is synthesized from ATP by adenylyl cyclase.
cAMP concentration, duration, and distribution depend on the activity of phosphodiesterase, which
degrades cAMP [103]. cAMP then binds to target proteins such as Protein Kinase A (PKA).
1.4.3 Transcription factors-CREB
Transcription factors are proteins that function downstream in the signaling cascade and
are involved in the process of initiating and regulating the transcription of DNA into RNA. CREB,
the best characterized stimulus-induced transcription factor, was originally identified as a target of
the cAMP signaling pathway, but is now known to be activated by several kinases including PKA,
Protein Kinase C, and p90 ribosomal S6 kinase [104-105]. Activation through all of these
pathways leads to a post-translation modification (PTM), phosphorylation, of CREB at the serine
133 residue, which then interacts with CREB-binding protein to initiate transcription of CREBresponsive genes [105]. CREB contains a C-terminus basic domain that binds to DNA target
sequences and a leucine zipper domain that controls dimerization, while the remaining domains
help facilitate interactions with coactivators to ultimately carryout RNA synthesis [105-106].
1.4.4 Transcription and translation
The flow from DNA to protein is transmitted through messenger RNA (mRNA). The main
enzyme involved in transcription is RNA polymerase, which synthesizes RNA molecules to form
the complementary base pair of the DNA sequence in the form of pre-mRNA. Pre-mRNA must
undergo extensive processing, removing introns and splicing together exons, as well as capping
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the 5′ end and polyadenylation at the 3′ end [107]. The mature mRNA is then transported to the
cytosol where it is translated into protein by ribosomal RNA using transfer RNA to supply the
amino acids to the peptide chain [107].
1.4.5 Post-translational modifications
As mentioned with CREB, signaling networks are regulated by the presence of PTMs.
PTMs involve the attachment of small chemical moieties to amino acid residues (e.g.,
phosphorylation, acylation, alkylation, glycosylation) [101]. The most common mechanism to
regulate function and transmit signals in cell signaling is phosphorylation [108]. The importance
of phosphorylation in cell signaling is demonstrated by the fact that protein kinase domains are
found in 1.5-2% of genes [109-110]. Protein kinases can adopt an “on” or “off” switch following
the transfer of γ-phosphate of ATP to the hydroxyl group of serine, threonine, or tyrosine. The
spatial and temporal control of phosphorylation on serine and threonine residues include cell-cycle
progression and cellular growth, while tyrosine phosphorylation controls cellular proliferation and
differentiation [111-112].
1.4.5.1 Mitogen-activated protein kinases (MAPKs)
MAPKs have been studied in numerous diseases because of their diverse role in regulating
proliferation, differentiation, gene expression, cell survival, and apoptosis. MAPKs can be
stimulated by a plethora of stressors and work upstream to phosphorylate diverse substrates that
leads to a cascade of signaling events that initiate changes for the appropriate biological response
[113]. Overall, MAPKs are grouped into three main families: extracellular signal-regulated kinases
(ERKs), c-Jun N-terminal kinases (JNKs), and p38.
The ERK1/2 pathway is the best studied pathway in the MAPK system. Activation of the
ERK pathway occurs by various stimuli including signals from cell-surface cytokine receptors
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(e.g., IL-3, GM-CSF) [114-115]. Activation of this pathway has been extensively studied and it is
well understood that cell surface receptors activate small GTPase RAS, which recruits RAF for
subsequent phosphorylation [116-117]. RAF, in turn, activates MEK1/2, which then
phosphorylates ERK1/2. The activation of this cascade regulates proliferation, differentiation, and
apoptosis [117-118].
JNKs are activated by environmental stressors (oxidative stress, heat, DNA damage) and
inflammatory cytokines. There are three genes (with 12 isoforms) that encode JNK: JNK1 and 2,
which are found in nearly every cell and JNK3 that is mainly found in the brain [119-120].
Signaling occurs through the mitogen-activated protein kinase kinase (MKK) 4 and 7, which lead
to the phosphorylation of JNK. Generally, JNK is a pro-apoptotic pathway and plays a critical role
in apoptosis, angiogenesis, and migration [119, 121]. Interestingly, this pathway acts as a critical
point between the adaptive and innate immune responses because it can be activated by Toll-like
receptor ligands as well as proinflammatory cytokines [122].
p38, like JNKs, are activated by environmental stressors (UV irradiation, heat,
lipopolysaccharide) and inflammatory cytokines [120]. p38 signaling is activated by MKK3 and
MKK6 kinases, but can also be activated by MKK4 [119, 121]. There are 4 genes that encode p38:
p38α and p38β that are ubiquitously expressed, and p38γ and p38δ that have more restrictive
expression [119, 123]. p38 plays a tumor suppressor role and can regulate inflammation, apoptosis,
differentiation, and cell cycle regulation [113, 119].
1.4.5.2 Phosphatidylinositol 3‑kinase (PI3K)/protein kinase B (AKT)
The phosphatidylinositol 3‑kinase (PI3K)/protein kinase B (AKT) signaling pathway has
also been extensively studied as a hallmark for many different disease states, especially cancer
[124-125]. This pathway responds to a number of stimuli, including growth factors and cytokines
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[125-128]. The PI3K/AKT pathway is highly conserved following a tight multi-step process
similar to ERK: activation of PI3K converts phosphatidylinositol (4,5)-bisphosphate (PIP2) to
phosphatidylinositol (3,4,5)-trisphosphate (PIP3), which then activates AKT [129]. This pathway
plays a role in regulating diverse cellular functions such as metabolism, proliferation, survival, and
growth [128].

Figure 1.2. Simplified PI3K/MAPK signaling pathways. Physiological and environmental stimuli can phosphorylate
a number of signaling pathways including the mitogen-activated protein kinase (MAPK) and the phosphatidylinositol
3‑kinase (PI3K) signaling pathways. See text for details.

1.4.5.3 Signaling crosstalk
Importantly, while these pathways have been well studied separately, recent research has
focused on the crosstalk between pathways [130-131]. For example, the ERK1/2 and PI3K
pathways were originally modeled as linear signaling pathways, activated by different stimuli, but
15

research has demonstrated that these pathways can regulate each other and, together, can regulate
common downstream functions [132]. This multi-pathway crosstalk can lead to highly extensive
networks with significant complexity based on diverse cellular responses to the same stimuli [127,
132]. Thus, after the toxicant exposure, the organism-level response must be organized via spatial
(e.g., brain region and/or cell type) and temporal (e.g., acute and adaptive) cellular responses, to
provide the appropriate insight into both the short- and long-term implications in response to
stressors [101, 133-134].
1.4.5.4 Spatiotemporal Response
The initial cell signaling responses post-exposure to stressors can be monitored within the
first few seconds to minutes, but the time course to cell death can have a vast range (several hours
to even days) [135-138]. Moreover, analysis of discrete tissue regions allows discrimination of
local xenobiotic toxicity that may otherwise go undetected in pooled samples [139]. By observing
discrete tissue regions at specific time points, one is able to get a more complete organismal
response to these various stressors (e.g., infection, trauma, exposure, etc.) [140-142].
1.5 Biological modeling
When investigating the biological response to stressors and attempting to extrapolate
studies to human diseases, it is important to choose an appropriate model. While in vitro assays
are high throughput, they provide only a simple snapshot of a controlled environment. In vivo
studies can provide a comprehensive analysis of a complete biological system. Typically, these
include animal models, from rodents to primates that can provide more insight and can be
extrapolated to the human population.
Many studies often focus on in vivo exposures to a single xenobiotic, but, for the most part,
humans are constantly exposed to a number of complex mixtures on a daily basis, including stress
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[143-145]. In 2015, 24% of adults in the United States reported extreme levels of stress and roughly
33% reported significant increases in stress levels from the past year [146]. In 2020, COVID-19
led to an increase to about 60% of people experiencing increased stress [147]. Thus, to more
adequately represent exposures, it is important to address the mixed exposure profile, especially
with stress (i.e., cortisol).
1.5.1 Routes of exposure
To get the most relevant information to the human population, it is also important to
consider the different types of in vivo exposures. The most common dosing methodology include
oral, dermal, inhalational, and injection (e.g., subcutaneous, intraperitoneal, intramuscular). While
injections might be the least appropriate to “real-life” exposures, it is commonly used because it
produces the highest bioavailability of the substance since it avoids first-pass elimination
(xenobiotic is metabolized before reaching its site of action) [101, 148-150]. This route
circumvents some of the unpredictability of the concentration that is administered.
1.5.2 Sample types
Biological samples, such as tissues, blood, urine, and saliva are used in a variety of fields
for basic, clinical and epidemiological studies to measure the biological response to stressors [152].
In both human studies and animal models, it is critical to test the appropriate biological sample
and acknowledge a systemic versus localized response. For example, in a physical trauma (i.e.,
broken femur) it may be important to monitor the immediate localized tissue healing response, but
a psychological stressor (i.e., a competition) might best be monitored by looking at a systemic
response. Despite knowing a target organ for an exposure (e.g., diisopropyl fluorophosphate, an
AChE inhibitor, will target the brain), accessibility to the target tissue is also important, especially
in studies involving chronic exposures. In order to monitor an animal over time, systemic
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measurements (blood, saliva, sweat, cerebral spinal fluid) may need to be taken until euthanasia to
avoid large numbers of animals. This dissertation will focus on two types of biological sampling:
ex vivo tissue and saliva.
1.5.2.1 Ex vivo tissue
Ex vivo tissue sampling can provide the localized spatiotemporal snapshot of the biological
response to a stressor. When obtaining tissue samples, it is important to be aware of euthanasia
methods and how this can affect the tissue prior to testing. Some common euthanasia techniques,
including inhalation of carbon dioxide, decapitation, or cervical dislocation, are used because of
their low cost (if any) and ease of use, but can have profound effects on certain analytes of interest,
the tissue quality, and data reproducibility [153]. Conversely, a less common technique such as
focused microwave irradiation, can preserve the steady-state levels of biological activity as well
as maintain tissue quality [154].
Once euthanized, tissue samples can be excised and snapped frozen to mitigate potential
gene alterations or protein phosphorylations [155]. It may also be important to further isolate
specific cell (e.g., immune cells) or muscle types (e.g., skeletal muscle) for a more focused
investigation. However, it is important to acknowledge inconsistencies in tissue samples, such as
size of sample, scar tissue, fat, etc., that occur by human error. These differences can yield
apparent significant findings that are inconsistent with the true responses.
1.5.2.2 Saliva
Saliva provides a simple, noninvasive method (compared to the traditional diagnostic fluid,
blood) that can be used to detect both localized and systemic responses of inflammation [156].
Saliva does not require immediate processing or qualified personnel to collect and can be sampled
multiple times in a single day without significant limitations [22]. Saliva consists of 98% water,
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but, more importantly, contains hormones, peptides, electrolytes, mucus, and various enzymes that
are also found in the blood [157-158]. Numerous studies have demonstrated blood is significantly
correlated to some salivary biomarkers when observing both physical and psychological stressors
[22, 68-69]. While saliva provides a unique opportunity to monitor inflammatory responses, there
are a number of complications that can cause an inflammatory response not necessarily related to
the stressor of interest, including localized inflammation caused by gingivitis and sores/cuts.
Additionally, various foods or medicines, time of day, or mouth pH can also affect the saliva
sample [159].
1.6 Measuring stress responses
A vast range of experimental techniques have been established to measure biological
responses, such as cellular and tissue-based biomarkers. Enzyme-linked immunosorbent assays
(ELISAs) are one of the most common biomarker assays because of the ability to detect and
quantify a variety of substances, including antibodies, antigens, proteins, and hormones [160].
Within this dissertation, several different multiplexed bead-based ELISAs were used to
measure the biological response using a Bio-Plex 200 (flow cytometer). These assays are widely
manufactured and can measure a number of different analytes including cytokines, total protein
levels, and phosphorylated protein levels. Using this method is attractive due to the ability to
multiplex hundreds of targets, using little sample volume, and short incubation times, while being
high-throughput and maintaining high sensitivity and specificity [161].
Specifically, a bead-based ELISA manufactured by Luminex uses colored polystyrene
microspheres, which can be magnetic, and are created by specific ratios of two fluorescent dyes.
These beads are then conjugated to a specific capture antibody based on the particular biomarker
of interest. To measure the samples, this technique uses a dual laser system which contains two
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laser beams to provide two wavelengths of excitation. In the flow cytometer, one laser (red laser
635nm) is used to identify the analyte of interest (based on the specific bead dye ratio) while the
second laser (green laser 525 nm) determines the concentration of the reported dye [161]. Thus,
due to the unique bead regions of the microspheres and the dual laser system, one can
simultaneously quantify hundreds of targets in a single well on a 96-well plate.

Figure 1.3. Bead-based sandwich ELISA. A polystyrene microsphere, which can magnetic, has a specific ratio of two
fluorescent dyes within the bead. The assay follows a typical sandwich ELISA: the sample binds to a capture antibody
that is immobilized on the bead, the biotinylated detection antibody binds to a specific epitope of the antigen, and a
fluorescent reporter (streptavidin-phycoerythrin) is added. The dual laser system in the flow cytometer can then
identify the bead type (for the analyte of interest) and quantify the reporter dye.

Physiological measurements (e.g., heart and respiration rates) provide real-time data that
can be directly related to the biological response to stressors. As previously mentioned, the SNS
is responsible for increasing both heart and breathing rates as part of the fight or flight response.
Therefore, in addition to cellular biomarkers, physiological metrics can be monitored to observe a
more complete response of the SNS to various stressors. Today there are numerous wearable
technology sensors that can be used in human studies to constantly monitor heart rate, breathing
rate, activity, etc., including smart watches and Zephyr™ sensors. The combination of data
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obtained from the physiological and biological metrics allows for a more complete understanding
of the organismal response to complex stressors.
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Chapter 2: Salivary cytokines as a biomarker of social stress in a mock rescue mission
Parts of this chapter have been published previously: Julia A. Penatzer, Julie V. Miller, Alice A. Han, Nicole Prince,
Jonathan W. Boyd (2020) Salivary cytokines as a biomarker of social stress in a mock rescue mission. Brain, Behavior
and Immunity-Health, 4, 100068. https://doi.org/10.1016/j.bbih.2020.100068

Using salivary inflammatory markers as a noninvasive biomonitoring technique within
natural social contexts has become increasingly important to link social and biological responses.
Many studies have associated circulating cytokines to distinct aspects of physical activity and
social/emotional behavior; however, they have not been linked to success and failure in a
naturalistic setting for military personnel performing tasks. In this study, salivary cytokines were
studied in a group of fifteen Air Force Reserve Officers’ Training Corps (ROTC; 14 males, 1
female) subjects performing three mock hostage rescue missions, designed to prompt responses
associated with baseline, success, and failure. Each subject completed the tasks of the mission
individually and again in randomly assigned teams. Participants were outfitted via direct skin
contact with comfortable external ZephyrTM sensors to monitor heart rate, breathing rate, and
activity while completing each task. Saliva samples were collected before and after the completion
of each mission, and cytokine levels were quantified using enzyme-linked immunosorbent assay
(ELISA) beads. These biomarkers were used to describe the body’s immune response to success
and failure when performing a mock rescue mission individually and in a team. All measured
cytokine levels increased following failed missions performed individually, compared to cytokine
levels associated with successful missions. When completing the tasks as a team, there were no
significant differences in cytokine response between success and failure; however, being in a team
stimulated an increased pre-mission cytokine response, suggesting the concept of teamwork and
34

performing with peers for the first time had a more significant impact than the notion of failing.
Additionally, none of the cytokines tested for individual missions correlated to physical activity
markers (heart rate, breathing rate, activity) measured during performance. These results indicate
a potentially new noninvasive method of determining social stress levels under taxing conditions.
2.1

Introduction
Social settings are known to stimulate immune responses related to stress and

inflammation [1-3]. In the presence of stress-induced stimuli, the communication between the
brain and the body occurs through the autonomic nervous system, as well as the endocrine and
immune systems [4-5]. This communication relies on the release of dynamic biochemical
messengers to promote adaptation in response to social, mental, and physical stressors [6]. When
these messengers are triggered, they can be measured as early as minutes after an individual
perceives the stimuli [7].
While measuring these biochemical messengers is critical to understanding the dynamic
biological cascades associated with social, mental, and physical stressors, research has been
limited because temporal data can be restricted if solely relying on blood as a sample. Sampling
with saliva provides a simple, noninvasive method, as an alternative to serum samples, that does
not require immediate processing or qualified personnel to collect [1]. Moreover, multiple saliva
collections can be obtained on the same day and repeated over time without significant limitations.
Saliva consists of 98% water that contains hormones, peptides, electrolytes, mucus, and various
enzymes that are also found in the blood [8-9]. Recent studies have demonstrated blood, the
standard diagnostic fluid, is significantly correlated to some salivary biomarkers while monitoring
physical activity as well as psychological stress [1, 10-11].
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Cytokines are soluble glycoproteins secreted by immune cells and found in both blood
and saliva samples [1, 12-13]. They have been extensively studied in relation to physical activity
and short-term exercise, which affects both local and systemic production in response to muscle
fatigue [14-15]. More importantly, several studies have examined the effects of social stressors on
cytokines [1, 16]. Dickerson et al. (2004a), demonstrated that individuals who wrote about an
experience that induced feelings of shame displayed an increased inflammatory cytokine response
versus those who wrote about a control topic [17-18]. Emotional states created by social ties, such
as anxiety, anger, and depression, also have been shown to increase proinflammatory cytokines [1,
19-20]. Chiang et al. (2012) demonstrated that individuals who experienced both negative and
competitive social interactions displayed heightened proinflammatory cytokines [16].
Additionally, studies have shown social defeat promotes an increase in cytokine response [21-23].
Thus, cytokines provide a new objective and quantifiable biological target that may be explored in
relation to success and failure as a response to either physical or social stress.
To explore this concept, Air Force Reserve Officers’ Training Corps (ROTC) cadets were
enrolled to perform a mock hostage rescue mission individually, and later in teams. Subjects wore
an external ZephyrTM (Zephyr Performance System, Boulder, CO) monitor that collected physical
activity data during all of the missions. A saliva sample was collected from each subject before
the first mission and after the completion of each mission. Cytokine levels were measured using a
standard enzyme-linked immunosorbent assay (ELISA) kit. In contrast to current studies, the
present research combines physical activity with salivary cytokine concentrations for individuals
in response to both successful and failed missions, while performing as individuals and in teams.
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2.2

Materials and methods

2.2.1 Participants
This study received approval from the Institutional Review Board (IRB) committee at West
Virginia University (IRB #1511920378) and the United States Army Medical Research and
Materiel Command (USAMRMC; IRB #H-24174). Air Force Reserve Officers’ Training Corps
(ROTC) cadets were enrolled to perform a mock hostage rescue mission. The subjects were
introduced to the study during a university ROTC course. A total of 16 subjects volunteered and
provided consent for the study; however, one subject failed to provide enough sample to test and
was removed from the analysis. Therefore, a homogenous cohort of 15 ROTC cadets (14 males, 1
female) were considered for statistical analyses (Table 2.1).
Table 2.1. Summary of subjects from mock crime scene house. Displayed are the means and standard deviation (SD)
from the subjects.

Mean±SD

Age (years)

Body Mass Index (kg•m-2) Body Fat %

19.53±1.1

23.95±2.8

15.52±6.0

2.2.2 Procedure
Three missions were completed by each individual and, on a separate day, by each team.
The subject was given the following mission to read:
“One of the houses outside is a known terrorist stronghold and possible bombmaking facility. After monitoring the facility for some time, we have determined their
occupancy habits. At this time, we know the structure to be vacant. It is, however, believed
to have a hostage inside; this hostage is believed to know valuable information and to be
sympathetic to our cause. The objective of this mission is to carefully canvass the building,
which means leaving no evidence of your presence behind (leave all belongings inside the
way you found it, lights off, doors closed), and search each room to find and rescue the
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hostage (punching bag). It is believed that the hostage has been injured and is possibly
unconscious. Our preliminary surveillance has shown that there is a backboard, hand cart,
and four bungee cords spread out somewhere in the building. You must find all the items,
figure out how to assemble all the items together, and carefully transport the hostage back
to the rendezvous point at the garage. I must stress the fact that the building must be left
in the state you found it, therefore, move quickly and quietly in the building and use caution
when entering and searching each room.”
During the first mission, the subjects/teams were instructed to complete the mission while being
timed to familiarize the participant with the crime scene house and the task at hand (baseline
mission). For the second rescue mission, the subjects/teams were instructed to go as fast as they
could, but still abide by the mission objectives and rules (considered a successful mission). During
the third hostage rescue mission, the subjects/teams were informed that they would be timed again;
however, this time, one minute into the mission, an air horn was blown and the mission director
stated, “Insurgents are returning: You have one minute left or you will be captured!” The second
horn blew one minute after the first horn and the mission director yelled “FAIL! Assemble the
hostage and come back to the rendezvous point” (considered a failed mission). The timer was
started for each mission as soon as the subject/team entered the house and ended as soon as they
came back to the rendezvous spot and was recorded in seconds. For each mission, all four items
(hostage, backboard, hand cart, bungee cords) were randomly assigned to different locations in the
house.
2.2.3 Physical activity markers
Participants were outfitted via direct skin contact with comfortable external ZephyrTM
sensors (Zephyr Performance Systems) to continuously monitor heart rate, breathing rate, and
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activity levels while completing the mission. Heart rate was measured by a sensor in the strap
which detects heart electrocardiogram signals, while breathing rate was measured via a pressure
pad to detect the expansion of the rib cage, and an internal accelerometer measured the subject
activity [24]. Physical activity markers were calculated using the summed physical activity level
(i.e., heart rate) while completing the mission normalized to the time to complete the mission (i.e.,
beats/second). As previously mentioned, the timer was started as soon as the subject/team entered
the house and ended as soon as the subject(s) came back to the rendezvous spot.
2.2.4 Saliva samples
Saliva samples were collected before the first mission (baseline; approximately 19:00) and
after the completion of each mission (baseline, success, and failure). Prior to saliva collection,
subjects were given an 8 oz bottle of water and instructed to immediately drink it. Ten minutes
after each subject finished their water, a 1-mL sample was taken with the help of a saliva collection
aid (Salimetrics, Carlsbad, CA). Immediately after collection, the saliva samples were stored on
ice and later transferred to a freezer (-80°C) until analysis. On the day of analysis, samples were
centrifuged at 3000 rpm for 15 minutes at 4°C.
2.2.5 Cytokine 10-plex assay
The saliva supernatant was assayed for the following cytokines via an ultrasensitive human
cytokine 10-plex panel including: interleukins (ILs)- 1β, 2, 4, 5, 6, 8 and 10, granulocytemacrophage colony-stimulating factor (GM-CSF), tumor necrosis factor alpha (TNF-α), and
interferon gamma (IFN-γ) (Fisher Scientific, Pittsburgh, PA). The samples were analyzed with the
Bio-Plex 200 suspension array system and Pro II Wash Station (Bio-Rad, Hercules, CA),
according to the manufacturer’s instructions and performed in triplicate (inter assay variation
<10%).
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2.2.6 Statistical analysis
All data analyses were performed using GraphPad Prism V5 (San Diego, CA) and SAS
JMP Pro V14 (Cary, NC). The samples were quantified using the provided standards from the kit.
Two cytokine targets, IL-1β and IL-8, were consistently above the highest standard for all
participants and were removed from the dataset. Responses from the female subject did not
significantly affect the analyses and therefore was included in all of the datasets. Data are presented
as means ± standard error of the mean (SEM), and significance tests were performed using the
Friedman test or the Wilcoxon matched-pairs signed rank test, where appropriate. Dunn’s posttest was also performed to determine significant changes in cytokine levels across missions. Values
were considered statistically significant at a 5% level of significance (p<0.05). Pearson correlation
analyses were also conducted for cytokine and physical activity marker data; however, none of the
correlations were considered statistically significant at a 5% level of significance (p>0.05) (data
not shown). Additionally, Pearson correlations were run between cytokine concentrations and age,
body fat percentage, and body mass index (BMI) for each subject to determine the possible
contribution of these variables. None of the correlations between cytokine levels and age, body fat
percentage, or BMI were significant (p>0.05) (data not shown).
2.3

Results

2.3.1 Physical activity markers of stress
Using external ZephyrTM sensors, the physical activity markers (heart rate, breathing rate,
and activity) were calculated using the summed marker normalized by the time (seconds) it took
to complete the mission. There was a significant increase in activity for individuals compared to
baseline for success and failure (p<0.05). Conversely, there was no significant difference for
success and failure for individuals or for teams for heart rate, breathing rate, and activity (p>0.05)
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(Figure 2.1). However, heart rate and activity were significantly decreased for individuals in a
team compared to individual tasks for failed missions. Heart rate was also significantly decreased
for individuals in a team for successful missions.

Heart Rate
Beats/Second

200
150

*

#

*

#

100
50
0

Individual

Team

Breathing Rate
Breaths/Second

40
30
20
10
0

Individual

Team

Activity
Movements/Second

0.5
0.4

#

#

0.3
0.2
0.1
0.0

Individual

Baseline

Team

Success

Failure

Figure 2.1. Physical activity markers of stress in a mock rescue mission. Physical activity was measured for individuals
(n=15) while completing a mission as individuals and part of a team using external Zephyr TM sensors. Physical activity
markers were calculated using the summed activity (generated by ZephyrTM) normalized by the time (seconds) it took
to complete the mission as described in Materials and Methods. The physical activity metric was averaged for all
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individuals. Significance levels were determined using the Friedman test with a Dunn’s post-test, where # and *
indicate significance (p<0.05) between an individual and team mission. Bars indicate significance (p<0.05) within
individual or team missions. Data are represented as mean ± SEM.

2.3.2 Individual salivary cytokine response to success and failure
Cytokine concentrations were measured in saliva when the subjects first arrived (premission) and ten minutes post completion of each mission (baseline, success, and failure). All eight
cytokines displayed significant increases (p<0.05) following the failed mission compared to
success (Figure 2.2) determined by the Friedman test with Dunn’s post-test. Conversely, a
significant decrease in cytokine response was observed following the successful mission compared
to baseline for IL-6 and TNF-α (Figure 2.2).
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Figure 2.2. Salivary cytokine concentrations following individual missions. Cytokines were measured for individuals
(n=15) while completing a mission as individuals. Cytokine responses (IL-10, IL-6, GM-CSF, IL-5, IFN-γ, TNF-α,
IL-2, IL-4) were measured in saliva after each mission using a multiplex ELISA as described in Materials and Methods.
Significance levels were determined using the Friedman test with a Dunn’s post-test. Bars indicate significant
differences (p<0.05) between missions. Data are represented as mean ± SEM.
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2.3.3 Team salivary cytokine responses to success and failure
Cytokine concentrations were also measured in saliva after the team missions. While
performing as a team, none of the cytokines displayed significant differences between baseline,
success, and failure (Figure 2.3). However, the baseline cytokine response for individuals on the
day of the team mission were significantly increased (p<0.05) compared to the day of individual
completion determined by Wilcoxon matched-pairs signed ranked test (Figure 2.4).
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Figure 2.3. Salivary cytokine concentrations following team missions. Cytokines were measured for individuals (n=15)
while completing a mission on teams. Cytokine responses (IL-10, IL-6, GM-CSF, IL-5, IFN-γ, TNF-α, IL-2, IL-4)
were again measured in saliva after each mission. There were no significant differences (p>0.05) as determined by the
Friedman test with a Dunn’s post-test. Data are represented as mean ± SEM.
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Figure 2.4. Cytokine responses pre-mock rescue missions. Cytokines were measured for individuals (n=15) before
completing the missions as individuals and as teams. Significance levels were determined using the Friedman test
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with a Dunn’s post-test, where bars indicate significant differences (p<0.05) between individual and team baseline.
Data are represented as mean ± SEM.

2.4

Discussion
Social ties are highly important for survival, and thus threats to our social connections (e.g.,

rejection, isolation, conflict, or loss) signal to our body that one is more vulnerable and may face
a greater likelihood of wounding and infection and, as such, a greater need for inflammatory
activity marked by increased cytokine concentrations is needed [25]. Within this study, Air Force
ROTC cadets were enrolled to perform a mock hostage rescue mission and cytokine responses
were measured in combination with physical activity to better understand the individual stress
response to success and failure in high stress field situations.
The ZephyrTM bioharness device provides reliable and valid measurements that can be
continuously taken and monitored while completing activities [26]. The wearable device provides
various physical activity parameters, such as heart rate, breathing rate, and activity levels, which
are important in monitoring physical intensity during exercises. Within our study, there were no
significant differences in physical load as determined by heart rate, breathing rate, and activity
levels between success and failure while completing the missions as individuals or in a team setting
(Figure 2.1). However, we did observe an increased response for individuals for success and failure
from baseline for activity/time. Due to the fact that participants were instructed to complete tasks
as quickly as possible during the successful and failed missions, it was expected that the subjects
would move more efficiently during these two tasks. Additionally, there was a decreased response
for the averaged team heart rate and activity from the individual metrics, which is expected due to
the shared physical load while completing the mission in teams.
Salivary biomarker analysis provides a unique opportunity to collect saliva multiple times
on the same day, without significant limitations. As such, within this study, cytokine levels were
47

able to be monitored following completion of each mission. After a failed mission, cytokine levels
were found to be significantly increased for all of the measured cytokines compared to success
(Figure 2.2). These increased responses of failure may be reflective of a defeat resulting in
psychological stress or anxiety [27-28]. In addition to the 2004 study, Dickerson et al. (2009)
demonstrated that individuals who performed the Trier Social Stress Test in front of an evaluative
panel showed increases in proinflammatory cytokines from pre- to post-stress compared to those
individuals who performed the same task, but completed it alone (eliminating the social stress)
[29]. Likewise, in our experimental setup, the individuals returned to the rendezvous point where
all the investigators and ROTC commanders were waiting. Thus, these increased cytokines may
be in response to the social defeat experienced in front of a group. Conversely, successful missions
resulted in decreased cytokine levels compared to baseline for IL-6 and TNF-α (Figure 2.2). This
lack of inflammatory response is likely a feeling of relief or acceptance within the social setting
after performing well.
Pearson correlation analyses were completed to determine if any significant correlations
existed between physical activity metrics and cytokine levels within each mission. There were no
significant correlations (data not shown) for any of the individual missions to the physical activity
data. These results indicate the cytokine responses observed for individual failure and success for
the subjects undergoing a mock rescue mission were independent of physical stress.
To further understand if the cytokine responses were a result of social or mental stress, a
repeat study was performed on the same individuals in a team environment. Neither success nor
failure caused a significant difference while performing as a team (Figure 2.3). Thus, in the team
setting, the same response to success and failure is not experienced, but they were still experiencing
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the same mental stimulation. These results indicate that the increased inflammatory response is
not a result of mental stress.
Interestingly, the pre-mission cytokine levels measured on the day of completion for
individuals in a team were significantly higher than on the day of individual mission (Figure 2.4).
The human body, especially the endocrine, immune, and cardiovascular systems, is exceedingly
sensitive and responsive to social interactions [30]. In this study, cytokine responses were
immediately heightened in a team setting compared to an individual setting without any physical
or mental stimulation. Thus, the increased immune response to the team setting further indicates
the elevated cytokine levels in response to failure for individuals are in response to social stressors.
2.5

Conclusions
In summary, using a noninvasive biomonitoring technique, this study was able to determine

cytokine levels in response to success and failure. Furthermore, individuals experienced higher
cytokines in response to failure and to a team setting. Additionally, the individual cytokine
responses did not correlate to physical load as measured by a ZephyrTM bioharness. These
cytokines could be important to better understand social stress during a physical exercise,
especially for military personnel (and possibly could be extended to sports teams in the future).
Importantly, this study was conducted in a naturalistic setting for these personnel and followed
subjects through three distinct scenarios (baseline, success, and failure). It should be noted that
one limitation of this study was small sample size (15 subjects). However, the sample size does
meet statistical power analysis standards, and future research will aim to increase the size of the
teams to explore larger groups. While these results indicate a noninvasive method of determining
social stress levels under challenging conditions, this relationship should be further investigated to
better understand potential differences in cytokine levels among genders.
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Chapter 3: Corticosterone ameliorates diisopropyl fluorophosphate-induced MAPK
phosphoprotein signaling in a mouse brain

Each year, millions of people are exposed to organophosphates (OPs) which may lead to
nerve agent induced seizures and irreversible brain injury. Even those that survive acute OP
exposure report continued symptoms of adverse neurological effects years later. Previous highexposure OP research has shown the activation of MAPK signaling pathways depending on the
type of OP and brain region, but the focus of this research has been on OPs in isolation. Certain
occupations (e.g., military, farmers, and pest control specialists) are more vulnerable to high dose
OP exposure and are also susceptible to high levels of occupation-related stress. To address a more
realistic mixture exposure, corticosterone (CORT) has been used to stimulate a response associated
with high stress that would likely be simultaneously experienced during OP exposures. Previous
results have shown this combination increases neuroinflammation, but ameliorates acetylcholine
in discrete brain regions. As a follow-up to these experiments, an investigation into phosphoprotein
responses in discrete brain regions was performed to better understand the early cellular changes.
Using a mouse model, adult male C57BL/6J mice were exposed to CORT (200 μg/mL) in the
drinking water for seven days followed by a single injection of diisopropyl fluorophosphate (DFP;
4.0 mg/kg, i.p.) on day eight and euthanized 0.5, 2, and 24 h post-exposure. To evaluate brainregion-specific effects, 14 post-translationally modified protein targets were measured using
multiplexed enzyme-labelled immunosorbent assay (ELISA) beads for the cortex and
hippocampus. Brain region-specific phosphoprotein responses were found to significantly differ
from exposure to DFP alone (p-AKT, p-BAD, p-JNK, and p-SYK) and when combined with preexposure to CORT (p-SRC). Specifically, the phosphoprotein responses to DFP at 24 h activates
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phosphoproteins involved in mitogen-activated protein kinase (MAPK) signaling; however, when
pre-exposed to CORT these results were ameliorated. These results display the short-term
protective ability CORT may provide to OP exposure, but could relate to the delayed onset of
neurological effects.
3.1

Introduction
Organophosphate (OP) toxicity can result from household to occupational exposures (e.g.,

field workers, pesticide sprayers, military, etc.). The primary mode of action for OPs is inhibition
of acetylcholinesterase (AChE) by binding to the enzyme at the active serine site, which results in
cholinergic toxicity due to the persistent stimulation of the cholinergic receptors [1]. Coinciding
with AChE inhibition, acute and chronic exposure to OPs has shown to increase pro-inflammatory
cytokines, which in turn leads to neuroinflammation [2]. While many animal studies have been
conducted to better understand OP toxicity in isolation, relatively few studies have addressed the
impacts of stress on the toxicity of these OP nerve agents.
Those at an increased risk of high OP exposure (e.g., agriculture workers and military
personnel) have also been reported as some of the most stressful occupations [3-7]. Therefore, it
is important to study the combined effects of OP exposure and stress. To better reflect this exposure,
O’Callaghan et al. (2015), established a mouse model using the combination of an OP, diisopropyl
fluorophosphate (DFP), coupled with corticosterone (CORT; the rodent surrogate for cortisol) pretreatment at levels that would be associated with high stress [8]. The pre-treatment with CORT
enhanced neuroinflammation, assessed by qPCR of several pro-inflammatory cytokines (tumor
necrosis factor-α, interleukin 1β and 6), within the first six hours in the frontal cortex and
hippocampus when compared to DFP alone [8]. Interestingly, Locker et al. demonstrated when
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using this model that priming with CORT “recovered” AChE activity that was inhibited by DFP
alone [9], indicating the observed neuroinflammation may be independent of AChE inhibition.
Cytokine and AChE signaling, similar to those observed in this combinatory model, can
directly initiate cellular signaling changes in impacted tissues, which can be measured through
post-translational modifications (e.g., protein phosphorylation) at early time points post-exposure
[8-11]. Specifically, this includes the family of mitogen-activated protein kinases (MAPKs) that
are crucial in the cellular responses to cytokines and implicated in immune and neuroinflammatory
diseases [12-14]. Similarly, phosphoinositide 3-kinases (PI3Ks) are key in regulating several
mechanisms in the inflammatory response to external insults, and the dysregulation of this pathway
has been shown to be involved in multiple neurological diseases [15-16]. Therefore, an
investigation examining the phosphorylation of proteins, both upstream and downstream of these
pathways, within the first 24 h in a mouse brain post-exposure to CORT, DFP, and the combination
was undertaken. The proteins measured in this study, highlight the relationship between regulatory
stress and inflammatory pathways associated with early responses of neuroinflammation.
In the study presented here, adult male C57BL/6J mice were exposed to CORT (200 μg/mL)
in the drinking water for seven days, and, on the eighth day, were given a single intraperitoneal
(i.p.) injection of saline or DFP (4.0 mg/kg), based on the O’Callaghan et al. model (2015) [8].
Mice were euthanized 0.5, 2, and 24 h post-exposure via focused microwave irradiation to preserve
the steady-state levels of protein phosphorylation [17]. To elucidate the effects of cellular signal
transduction post-exposure to CORT, DFP, and a CORT+DFP mixture on discrete brain regions,
14 post-translationally modified protein targets were measured in the cortex and hippocampus.
This approach provides insight to the acute phosphoprotein signaling observed in CORT+OP
exposure based on the elucidation of relevant spatiotemporal phosphorylation responses.
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3.2

Materials and methods

3.2.1 Materials
The following drugs and chemicals were obtained from the sources indicated: CORT
(Steraloids Inc., Newport, RI, USA), DFP (Sigma-Aldrich Co. St. Louis, MO, USA), ethanol
(Sigma-Aldrich), phenylmethylsulfonyl fluoride (Sigma-Aldrich), and cell lysis buffer (Bio-Rad,
Hercules, CA, USA). A Pierce BCA assay was obtained from Fisher Scientific (Pittsburgh, PA,
USA) and includes albumin standards and working reagent. A custom Bio-Plex Pro multiplexed
magnetic bead-based immunoassay kit was purchased from Bio-Rad. The kit included capture
antibodies, biotinylated secondary antibody, standard diluents, streptavidin-phycoerythrin,
resuspension buffer, wash buffer, cell lysis buffer, and positive and negative controls.
3.2.2 Animals
Adult male C57BL/6J mice (approximately 8-12 weeks of age) were purchased from
Jackson Laboratory (Bar Harbor, ME, USA). All procedures were performed under protocols
approved by the Institutional Animal Care and Use Committee of the Centers for Disease Control
and Prevention, National Institute for Occupational Safety and Health, and the animal facility was
certified by the American Association for Accreditation of Laboratory Animal Care. Upon arrival,
the mice were individually housed in a temperature- (21 ± 1°C) and humidity-controlled (50 ±
10%) colony room that was maintained under filtered positive-pressure ventilation on a 12 h light
(06:00 hours)/12 h dark cycle. The plastic cages were 46 x 25 x 15 cm; cage bedding consisted of
heat-treated pine shavings at a depth of 4 cm. Mice were given ad libitum access to food and water.
3.2.3 Dosing
Mice (at least five/group; animals were arbitrarily assigned to groups by the experimenter)
were exposed to CORT and DFP as previously described [8]. Briefly, mice received CORT in the
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drinking water (200 μg/mL in 1.2% ethanol) for seven days prior to exposure (Figure 3.1). Control
groups received 1.2% ethanol water. At this exposure, CORT was found to be elevated, similar to
those who would be experiencing high stress levels and has been shown to accentuate, or “prime”,
the central nervous system to produce a robust proinflammatory response to neurotoxicants or
inflammogens [19]. On day eight, mice were given a single intraperitoneal (i.p.) injection of saline
(0.9%) or DFP (4.0 mg/kg) in the morning and returned to their home cage (experimenter was not
blinded). This exposure of DFP elicited seizure-like behaviors within minutes post-injection [19].

Figure 3.1. Dosing paradigm for corticosterone and diisopropyl fluorophosphate exposure. Timeline for administration
of diisopropyl fluorophosphate (DFP 4.0 mg/kg) after corticosterone (CORT) priming (200 μg/mL in 1.2% ethanol)
in drinking water.

3.2.4 Brain dissection
Mice were euthanized at three time points (0.5, 2, and 24 h post-exposure) by focused
microwave irradiation. By using focused microwave irradiation for euthanasia, changes to the
steady-state levels of protein phosphorylation in response to exposures can be preserved in the
brain to provide a snapshot of the early cell signaling alterations that result in long-term impacts
using a high-throughput approach [17]. Whole brains were removed from the skull and dissected
free-hand with fine curved forceps on a thermoelectric cold plate (Model TCP-2; Aldrich Chemical
Co., Milwaukee, WI, USA) into two brain regions: cortex and hippocampus. Samples were
immediately snap frozen and stored at -80°C until analysis. Mice that did not survive to the end
points were excluded from analysis.
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3.2.5 Protein quantification in brain regions
Protein extraction was performed using methods adapted from Hulse et al. (2004) [20].
One side of the brain region (e.g., left cortex) was transferred to a 2 mL tube, and 500 μL of cell
lysis buffer containing 2 mM phenylmethylsulfonyl fluoride was added. Samples were
homogenized using a sonic dismembrator (model 120; Fisher Scientific) on ice with 3 rapid pulses
for 3 seconds at 35% amplitude until tissue was sufficiently ground (about 5 times). The samples
were centrifuged at 4500 x g for 10 min at 4°C, and the supernatant was collected and stored at
-80°C until analysis. Total protein concentration was determined using the Pierce BCA assay in
duplicate, according to the manufacturer’s instructions. Briefly, albumin standards were generated
ranging in concentration from 0-2000 μg/mL in sample diluent. Each standard or unknown was
pipetted into a microplate well, and 200 μL of the working reagent was added. The plate was
incubated at 37°C for 0.5 h. Absorbance values were determined at 562 nm using an Infinite
M1000 plate reader (Tecan, Raleigh, NC).
3.2.6 Phosphoprotein analysis in discrete brain regions
For phosphoprotein analysis, sample homogenates were diluted to a total protein
concentration of 700 μg/mL with sample diluent and centrifuged at 15000 x g for 10 min at 4°C.
Samples were assayed using the Bio-Plex Pro multiplexed magnetic bead-based immunoassay
reagent kit for the following targets phosphorylated at the indicated amino acid residues: p-AKT
(S473), p-BAD (S136), p-S6 Ribosomal P (S235/S236; p-RPS6), p-SMAD2 (S465/S467), p-SRC
(Y416), p-SYK (Y352), p-CREB (S133), p-ERK 1/2 (T202/Y204, T185/Y187), p-GSK3α/β
(S21/S9), p-HSP27 (S78), p-IκBα (S32/S36), p-JNK (T183/Y185), p-MEK 1/2 (S217/S221), and
p-p53 (S15). Samples were analyzed using a Bio-Plex 200 suspension array system and Pro II
Wash Station (Bio-Rad), according to the manufacturer’s instructions. Briefly, Bio-Plex magnetic
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bead-based assays follow a typical sandwich enzyme-linked immunosorbent assay (ELISA)
protocol. Capture antibodies are covalently coupled to the beads and react overnight with analytes
in the sample. After several washes, a biotinylated detection antibody is added and incubated for
0.5 h. After another series of washes, the detection complex (streptavidin-phycoerythrin) is added
and incubated for 10 minutes. After a final series of washes, a resuspension buffer is added and
data are acquired on the Bio-Plex 200. Biological replicates were at least in quintuplicate, and
assay measurements were performed in duplicate (technical replicates). Bio-Rad lysate positive
(EGF-treated HEK-293, UV-treated HEK-293, H2O2-treated Ramos, EGF-treated SK-BR-3,
TNF-α-treated HeLa, and PDGF-treated NIH3T3) and negative (phosphatase-treated HeLa)
controls were used to ensure appropriate bead counts.
3.2.7 Statistical analysis
Power calculations were preformed using SAS JMP (V14; Cary, NC, USA) and was
determined to be four mice per group using previous standard deviations, a power of 0.8, and
α=0.05. No exclusion criteria were pre-determined.
Relative phosphorylation was determined for each target. The averaged raw values were
blank-subtracted, and any phosphoprotein non-detects (response was less than blank) were
removed before analysis. The blank-subtracted values were normalized to saline control at each
time point for each brain region. A Grubbs’ test was performed to remove any significant outliers
(α = 0.05). As previously mentioned, any non-surviving animals were also excluded from analysis.
Thus, these analyses resulted in at least N=4 animals for the CORT, DFP, and CORT+DFP groups
for all phosphoproteins in both brain regions. Data analyses were performed using GraphPad Prism
(V5; San Diego, CA, USA). The normalized phosphorylation ± the standard error of the mean
(SEM) for each exposure and time point were used to identify significant targets. Two-way
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analysis of variance (ANOVA) with Bonferroni post-test was used to determine significance using
GraphPad Prism. A significance level of 5 % (p<0.05) was considered statistically significant.
3.3

Results
The cortex and hippocampus were extracted from C57BL/6J mice following exposure to

saline control, CORT alone, DFP alone, and a combination of CORT and DFP. A panel of
phosphoproteins involved in regulatory stress and inflammatory pathways associated with early
responses of neuroinflammation were assayed from brain region samples via multiplex bead-based
ELISA. The phosphoprotein responses were normalized to saline controls in the cortex and
hippocampus at 0.5, 2, and 24 h post-exposure. While all of the saline, CORT alone, and
CORT+DFP mice survived at the 24 h time point, only 5 of 14 mice from the DFP exposure alone
group survived (36% survival rate). The increased mortality associated with DFP has been noted
by other researchers at this exposure level who have previously used this model [8, 21-23].
However, the activated signaling pathways from the surviving mice may reveal important
biomarkers with relevance to symptoms associated with acute OP exposure. Specific patterns
observed spatially and temporally are discussed over the following sections.
3.3.1 Relative phosphorylation responses in the cortex
Within the cortex, there were several phosphoproteins that were significantly different
(p<0.05) compared to other exposures in response to DFP alone exposure. Phosphorylated RPS6
and SMAD2 were significantly increased (p<0.05) at 0.5 h for DFP relative to CORT+DFP (Figure
3.2). At 2 h, p-RPS6 and p-HSP27 were also significantly increased (p<0.05) post-DFP exposure
relative to saline control (Figure 3.2). A significant increase (p<0.05) for p-JNK at 24 h postexposure to DFP alone compared to the other exposures was also observed (Figure 3.2).
Conversely, DFP alone caused a significant decrease (p<0.05) in phosphorylation for AKT at 24
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h (Figure 3.2) relative to CORT+DFP. Additionally, the combination of CORT+DFP resulted in a
significant decrease (p<0.05) in p-SRC at 24 h compared to all other exposures (Figure 3.2).
Phosphorylated HSP27 also was significantly increased (p<0.05) for CORT alone relative to saline
at 2 h (Figure 3.2).
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Figure 3.2. Significant phosphoprotein responses in the cortex via multiplex ELISA post-exposure to corticosterone
and diisopropyl fluorophosphate. Mice were exposed to control or 200 μg/mL CORT in drinking water for seven days
(Figure 3.1). On day eight, mice were given DFP (4.0 mg/kg, i.p.) or saline and euthanized via focused microwave
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irradiation at 0.5, 2, or 24 h post-exposure. Phosphoprotein responses were measured in the cortex after DFP exposure
using a multiplex ELISA for targets of interest, as described in Materials and Methods. Significance was determined
using two-way ANOVA with Bonferroni post-test, where the horizontal bars represent significance p<0.05 between
exposures within a specific time. Data are represented as mean ± SEM.

Temporally, there was a significant decrease (p<0.05) in phosphoprotein responses at 24 h
post-exposure compared to the early time points (0.5 h and 2 h) post-DFP alone exposure for pAKT, p-RPS6, p-CREB, and p-p53 (Table 3.1). Conversely, p-JNK was significantly increased
(p<0.05) at 24 h compared to the early time points for DFP alone. At 2 h, p-ERK1/2 and p-RPS6
were significantly increased (p<0.05) for CORT+DFP compared to 0.5 h and 24 h, respectively
(Table 3.1). Phosphorylated p53 was also significantly increased (p<0.05) at the 2 h time point for
CORT alone. Interestingly, HSP27 was significantly phosphorylated (p<0.05) at the 2 h time point
for all exposures.
Table 3.1. Significant temporal phosphoprotein responses in the cortex post-exposure to corticosterone and
diisopropyl fluorophosphate. Data are represented as mean ± SEM with at least N=4 for all phosphoproteins. Twoway ANOVA with Bonferroni post-test was used for determining significance, where * indicates a significant
difference (p<0.05) between 0.5 h vs. 2 h, # indicates a significant difference (p<0.05) between 0.5 h vs. 24 h, and %
indicates a significant difference (p<0.05) between 2 h vs. 24 h for a particular exposure.

Phosphoprotein

p-AKT (S473)

p-RPS6 (S235/S236)

p-SRC (Y416)

Exposure

Time (h)
0.5 h

2h

24 h

Cort

0.89 ± 0.05

0.96 ± 0.06

0.93 ± 0.09

DFP

1.14 ± 0.07

1.17 ± 0.13

0.58 ± 0.31

Cort+DFP 0.89 ± 0.05

0.88 ± 0.09

1.04 ± 0.09

Cort

0.52 ± 0.07

0.85 ± 0.29

0.57 ± 0.34

DFP

2.84 ± 0.60

2.96 ± 1.01

0.31 ± 0.15

#,%

Cort+DFP 0.99 ± 0.38

1.90 ± 0.63

0.04 ± 0.01

%

Cort

0.63 ± 0.14

0.87 ± 0.08

0.98 ± 0.09
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Significant

#,%

DFP

p-CREB (S133)

p-ERK1/2
(T202/Y204,
T185/Y187)

p-HSP27 (S78)

p-JNK (T183/Y185)

p-p53 (S15)

1.24 ± 0.07

0.73 ± 0.19

0.81 ± 0.13

*

Cort+DFP 0.91 ± 0.06

0.78 ± 0.20

0.34 ± 0.05

#

Cort

1.76 ± 0.64

2.25 ± 0.44

0.83 ± 0.16

DFP

1.41 ± 0.62

2.20 ± 1.03

0.16 ± 0.08

Cort+DFP 1.18 ± 0.39

2.67 ± 0.47

0.85 ± 0.21

Cort

1.35 ± 0.27

2.17 ± 0.73

1.06 ± 0.20

DFP

0.89 ± 0.24

1.71 ± 0.66

0.94 ± 0.32

Cort+DFP 0.66 ± 0.17

2.63 ± 0.87

1.27 ± 0.23

*

Cort

1.05 ± 0.22

2.82 ± 0.58

0.93 ± 0.11

*,%

DFP

0.85 ± 0.15

2.52 ± 0.46

0.60 ± 0.19

*,%

Cort+DFP 0.68 ± 0.13

2.20 ± 0.38

1.65 ± 0.21

*,#

Cort

1.11 ± 0.17

1.30 ± 0.28

1.11 ± 0.11

DFP

0.80 ± 0.11

1.78 ± 0.32

3.08 ± 1.09

Cort+DFP 0.81 ± 0.15

1.72 ± 0.33

0.82 ± 0.09

Cort

1.15 ± 0.21

1.67 ± 0.51

0.77 ± 0.05

%

DFP

0.85 ± 0.12

1.28 ± 0.21

0.45 ± 0.16

%

Cort+DFP 0.99 ± 0.18

1.30 ± 0.27

0.86 ± 0.09

%

#,%

3.3.2 Relative phosphorylation responses in the hippocampus
In the hippocampus, several phosphoproteins were again observed to have significant
differences (p<0.05) involving DFP at 2 and 24 h post-exposure. Similar to the cortex, p-SYK and
p-JNK were significantly increased (p<0.05) for DFP alone compared to CORT+DFP at 24 h,
while p-RPS6 and p-SMAD2 were increased relative to saline (p<0.05) at 2 h (Figure 3.3).
Additionally, p-MEK1/2, p-ERK1/2, and p-CREB were also significantly phosphorylated (p<0.05)
at 24 h for DFP compared to saline or CORT+DFP. Conversely, at 24 h, p-AKT was significantly
decreased (p<0.05) for DFP compared to CORT+DFP. Phosphorylated IκBα and SMAD2 were
significantly increased (p<0.05) for CORT-alone compared to saline at 0.5 h and 2 h, respectively
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(Figure 3.3). At 0.5 h, p-CREB was significantly increased (p<0.05) for CORT+DFP compared to
CORT-alone (Figure 3.3). Interestingly, p-BAD was significantly increased at 24 h for
CORT+DFP relative to CORT and DFP alone (Figure 3.3).
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Figure 3.3. Significant phosphoprotein responses in the hippocampus via multiplex ELISA post-exposure to
corticosterone and diisopropyl fluorophosphate. Using the same dosing regimen and euthanasia as stated in Figure 3.2,
phosphoprotein responses in the hippocampus were measured using multiplex ELISA for targets of interest. Two-way
ANOVA with Bonferroni post-test was used for determining significance, where the horizontal bars represent
significance p <0 .05 between exposures within a specific time. Data are represented as mean ± SEM.

Temporally, there was at least one significant difference (p<0.05) in each of the
phosphoproteins tested, with the exception of p-p53 (Table 3.2). DFP alone significantly
phosphorylated (p<0.05) HSP27 and CREB at 0.5 h, while at 2 h, p-SMAD2 and p-RPS6 were
significantly increased. DFP alone significantly decreased (p<0.05) p-AKT and p-SRC at 24 h
post-exposure. Alternatively, p-ERK1/2, p-GSK3α/β, p-JNK, and p-MEK1/2 were all significantly
increased (p<0.05) following DFP exposure at 24 h relative to the earlier time points (Table 3.2).
At 24 h, p-BAD was also significantly increased (p<0.05) compared to the earlier time points, but
following CORT+DFP exposure. Phosphorylated CREB was significantly increased (p<0.05) at
0.5 h relative to 2 and 24 h post-exposure for CORT+DFP. For p-AKT and p-SMAD2, CORT
alone and CORT+DFP caused significant increases (p<0.05) at 2 h compared to the other time
points. CORT alone also resulted in a significant increase (p<0.05) at 2 h for p-SRC and p-SYK,
while p-IκBα and p-MEK1/2 were significantly increased (p<0.05) at 0.5 h.
Table 3.2. Significant temporal phosphoprotein responses in the hippocampus post-exposure to corticosterone and
diisopropyl fluorophosphate. Data are represented as mean ± SEM with at least N=4 for all phosphoproteins in the
table. Two-way ANOVA with Bonferroni post-test was used for determining significance, where * indicates a
significant difference (p<0.05) between 0.5 h vs. 2 h, # indicates a significant difference (p<0.05) between 0.5 h vs.
24 h, and % indicates a significant difference (p<0.05) between 2 h vs. 24 h for a particular exposure.

Phosphoprotein

Exposure

Time (h)
0.5 h

p-AKT (S473)

Cort

0.77 ± 0.04

2h

24 h

Significant

1.34 ± 0.16

0.83 ± 0.11

*,%
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DFP

p-BAD (S136)

p-RPS6 (S235/S236)

p-SMAD2
(S465/S467)

p-SRC (Y416)

p-SYK (Y352)

p-CREB (S133)

p-ERK1/2
(T202/Y204,
T185/Y187)

p-GSK3α/β (S21/S9)

p-HSP27 (S78)

0.89 ± 0.10

1.26 ± 0.18

0.34 ± 0.18

#,%

Cort+DFP 0.80 ± 0.07

1.28 ± 0.15

0.84 ± 0.08

*,%

Cort

1.01 ± 0.01

0.98 ± 0.01

0.99 ± 0.11

DFP

0.96 ± 0.01

0.98 ± 0.01

0.96 ± 0.10

Cort+DFP 0.96 ± 0.01

0.98 ± 0.01

1.17 ± 0.01

Cort

0.67 ± 0.12

1.56 ± 0.35

0.37 ± 0.15

DFP

0.98 ± 0.19

2.77 ± 1.14

0.37 ± 0.15

Cort+DFP 0.78 ± 0.14

1.58 ± 0.43

0.27 ± 0.10

Cort

0.52 ± 0.11

2.29 ± 0.13

0.69 ± 0.08

*,%

DFP

0.91 ± 0.21

2.66 ± 0.37

0.64 ± 0.07

*,%

Cort+DFP 0.35 ± 0.06

2.27 ± 0.15

0.66 ± 0.11

*,%

Cort

0.83 ± 0.24

2.37 ± 0.60

0.28 ± 0.18

%

DFP

1.60 ± 0.54

2.24 ± 1.16

0.10 ± 0.05

%

Cort+DFP 1.28 ± 0.52

1.42 ± 0.51

0.17 ± 0.09

Cort

0.65 ± 0.12

1.23 ± 0.19

0.43 ± 0.10

DFP

1.18 ± 0.20

1.18 ± 0.22

1.61 ± 0.42

Cort+DFP 0.54 ± 0.06

0.89 ± 0.22

0.53 ± 0.23

Cort

1.13 ± 0.06

1.17 ± 0.08

0.92 ± 0.20

DFP

3.92 ± 0.17

2.13 ± 0.52

2.58 ± 0.74

*

Cort+DFP 3.15 ± 0.92

1.21 ± 0.18

1.46 ± 0.28

*,#

Cort

1.03 ± 0.18

1.23 ± 0.15

0.77 ± 0.15

DFP

0.90 ± 0.16

0.79 ± 0.14

2.03 ± 0.62

Cort+DFP 0.75 ± 0.15

0.74 ± 0.09

1.15 ± 0.19

Cort

0.80 ± 0.07

0.78 ± 0.13

0.72 ± 0.13

DFP

0.70 ± 0.09

0.74 ± 0.11

1.34 ± 0.38

Cort+DFP 0.72 ± 0.16

0.55 ± 0.06

0.80 ± 0.17

Cort

1.01 ± 0.17

0.37 ± 0.16

0.46 ± 0.29

DFP

1.19 ± 0.21

0.42 ± 0.18

0.39 ± 0.11

Cort+DFP 0.94 ± 0.28

0.33 ± 0.10

0.33 ± 0.13
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#

*,#

p-IκBα (S32/S36)

p-JNK (T183/Y185)
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(S217/S221)
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Cort

2.39 ± 0.87

0.45 ± 0.14

0.73 ± 0.17

*,#

DFP

1.57 ± 0.59

0.34 ± 0.10

1.40 ± 0.47

Cort+DFP 1.63 ± 0.57

0.29 ± 0.07

0.45 ± 0.07

Cort

1.77 ± 0.42

0.47 ± 0.13

0.64 ± 0.24

DFP

1.38 ± 0.34

0.36 ± 0.08

4.13 ± 1.73

Cort+DFP 1.12 ± 0.29

0.34 ± 0.07

0.53 ± 0.16

Cort

1.45 ± 0.37

0.34 ± 0.09

0.52 ± 0.15

*

DFP

0.92 ± 0.11

0.34 ± 0.11

1.67 ± 0.65

%

Cort+DFP 0.97 ± 0.25

0.22 ± 0.05

0.43 ± 0.11

#,%

Discussion
Each year, millions of people are exposed to OPs, and approximately ten percent of

exposures result in death, but even those that survive high-dose exposures report symptoms of
adverse neurological effects for years later [2]. Moreover, certain occupations that at an increased
risk for high-dose OP exposure are also most likely to have increased stress levels [3-8]. In order
to better understand this realistic exposure in these vulnerable groups, several researchers have
conducted animal studies using exogenous CORT, to replicate high organismal stress, in
combination with DFP, an irreversible OP AChE inhibitor [8, 24]. These experiments have been
informative showing increased and chronic neuroinflammation compared to DFP exposure alone
[8]. Conversely, inhibition of brain AChE activity by DFP appears to be ameliorated by prior
CORT exposure, suggesting a potential AChE-independent route to cause this neuroinflammatory
response [9, 25]. Thus, an investigation into early intracellular signaling responses via
phosphoprotein analysis in discrete brain regions was performed within this study to understand
the responses that may lead to these AChE-independent route of a chronic disease state.
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Previous research has highlighted the differences in the spatiotemporal progression of
intoxication of DFP and showed detrimental effects of exposure occur in the cortex first (typically
in the first 6 h), while lesions in the hippocampus are delayed until 12-24 h post-exposure [26-27].
The results in the present study agree, displaying delays in phosphoprotein responses in the
hippocampus relative to the cortex. Specifically, p-RPS6 and p-SMAD2 are significantly increased
(p<0.05) at 0.5 h post-DFP exposure in the cortex, but are not increased in the hippocampus until
2 h (Figures 3.2, 3.3). Additionally, SRC phosphorylation in the cortex begins to decrease after 0.5
h for all exposures, but is increased at 2 h post-exposure for the hippocampus and then decreased
by 24 h. Therefore, it is essential to observe the early cellular spatiotemporal responses that involve
post-translational phosphorylation events and regulate adaptive stress and inflammatory pathways
as these converge toward a new cellular- and ultimately organism-level steady state [28].
Elucidation of the spatiotemporal phosphorylation responses in combination with previous
research on neuronal signaling (e.g., neuroinflammatory markers, acetylcholine accumulation)
relevant to these exposures holds the potential to further discern the manifestations of continued
OP toxicity.
In both brain regions, statistically significant differences (p<0.05) are observed in
phosphoproteins involved in the MAPK signaling pathway in response to DFP alone, which agrees
with previous research indicating OPs activate this pathway [29-30]. Two of the main families of
MAPKs were measured within this study: ERKs and JNKs. Within this study, DFP alone led to
significant increases (p<0.05) at 24 h in phosphorylation for p-JNK in both brain regions, and pERK1/2 and p-MEK1/2 in the hippocampus (Figures 3.2, 3.3). Activation of the ERK pathway by
growth

factors

can

regulate

proliferation,

differentiation,

and

apoptosis

via

the

RAS/RAF/MEK/ERK cascade [31-32]. Conversely, JNKs are activated by environmental
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stressors and inflammatory cytokines (i.e., tumor necrosis factor-α, interleukin-1) and plays a key
role in regulating apoptosis [33-34]. Similar to the present study, previous OP exposure research,
has demonstrated significantly increased levels of phosphorylation of ERKs and JNKs postexposure and induce activation of apoptosis [35-38]. Therefore, the previously observed increases
in cytokines may be leading to the activation of p-ERK and p-JNK observed in the present study,
which may be resulting in cell death via apoptosis and ultimately lead to the observed animal death.
Our results indicate that DFP alone was also found to impact another key inflammatory
pathway, namely PI3Ks. Specifically, phosphorylation of p-AKT and p-BAD were decreased
following exposure to DFP alone relative to CORT+DFP. AKT is a pro-survival kinase that
inhibits pro-apoptotic activity by phosphorylating BAD at serine 136 and its sequestering partner
14-3-3 (Figure 3.4) [39]. However, JNK has been shown to phosphorylate 14-3-3, which releases
dephosphorylated BAD (Figure 3.4) [40]. From there, BAD targets the mitochondria and promotes
apoptosis while antagonizing the effects of AKT signaling [41]. While there are no statistical
differences in p-BAD in the cortex, this pattern is observed in the hippocampus, in which p-BAD
is significantly decreased (p<0.05) following DFP alone compared to CORT+DFP (Figure 3.3).
Moreover, p-AKT is observed to be significantly decreased (p<0.05) in both brain regions
following DFP exposure (Figures 3.2, 3.3). Thus, by observing the phosphorylation of these
proteins, spatially, our results indicate the differences in activating MAPK and deactivating PI3K
signaling for DFP alone relative to CORT+DFP. The overactivation of p-JNK and subsequent
decreases in p-AKT and p-BAD may be the potential cause of the decreased survival rate for the
DFP group (36%).
Phosphorylated SYK was also found to be increased by DFP at 24 h time points postexposure (Figure 3.3). SYK is involved in multiple biological processes, including adaptive
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immune response and innate immunity; it functions downstream of antigen receptors in immune
cells and plays an important role of distinguishing self and non-self [42-43]. Furthermore, SYK
has been shown to phosphorylate several downstream pathways including MAPK and PI3K
(Figure 3.4) [44-45]. Taken together, this target may explain the pathway associated with the
increased activation of p-JNK signaling.
While the combination of CORT+DFP ameliorates these significant phosphoprotein
responses that were caused by exposure to DFP alone, p-SRC was shown to be statistically
significant (p<0.05) for CORT+DFP across both brain regions (Tables 3.1, 3.2). The SRC family
kinases are highly expressed in the central nervous system and control many cellular events such
as cell growth, proliferation, and migration [46]. Within our studies, the combination of
CORT+DFP consistently causes a decrease in phosphorylated p-SRC (Tables 3.1, 3.2), which has
also been demonstrated in rodents after traumatic brain injuries [47-49]. It has been suggested that
the decrease in SRC phosphorylation leads to an increase in the degradation and overall loss of Nmethyl-D-aspartate receptors following brain injuries [49-50]. Furthermore, the loss of N-methylD-aspartate receptors has been linked to a number of major nervous system disorders including
neurodegenerative diseases, ischemia, pain, and depression [51]. Importantly, the SRC and SYK
kinase families usually operate together in signaling pathways involved in innate cell response,
with SRC being activated first in response to pathogens, followed by phosphorylation of SYK
(Figure 3.4) [52]. Moreover, p-SRC and p-SYK provide interesting biomarkers that unequivocally
link neuroimmune responses to previous findings (decreasing AChE and increasing
neuroinflammation post-exposure to DFP when primed with CORT) in this model [8-9, 25].
A summary of these phosphoprotein connections are presented in a network configuration
in Figure 3.4 below. While this is a single network, it is critical to note that this figure is attempting
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to represent significant spatiotemporal phosphorylation that are occurring post-exposure at
different times and in different brain regions. For example, DFP alone exposure significantly
(p<0.05) phosphorylates SMAD2, RPS6, and CREB at 0.5 h post-exposure, but at 24 h there is a
shift in phosphorylation; p-SYK and p-JNK are significantly increased (p<0.05), while the PI3K
and RAS/RAF/MEK/ERK pathways were both decreased. Meanwhile, CORT+DFP exposure at
24 h resulted in decreases in phosphorylation for SRC, SYK, and JNK, but increases in the PI3K
pathway. Similar to DFP alone, the RAS/RAF/MEK/ERK pathway was decreased at 24 h for
CORT+DFP exposure relative to the earlier time points. While limited, this network is an
important step to understanding the combination of OP exposure with CORT, which results in
early cytokine-driven inflammation. This will ultimately enhance our understanding of brain
specific responses that yield neuroinflammation in this model.
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Figure 3.4. Schematic depicting the relationship of SRC with SYK downstream PI3K and MAPK signaling. Binding
of the antigen (Ag) to the BCR increases activity of SRC. SYK is then recruited and becomes activated, promoting
recruitment and phosphorylation of downstream adaptor or scaffold proteins. Phosphorylation of SYK promotes
activation of the MAPK (i.e., JNK), PI3K/AKT, or RAS/RAF/MEK/ERK pathway. The PI3K/AKT pathway promotes
phosphorylation of BAD at the serine 136 residue and the association of BAD with 14-3-3, inhibiting pro-apoptotic
activity (cell survival). In contrast, JNK phosphorylates 14-3-3 leading to the dissociation of BAD from 14-3-3, a
decrease in phosphorylation of BAD, and the dimerization of BAD with Bcl-XL or Bcl2, eventually resulting in cell
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death. BCR, B-cell receptor; PI3K, phosphoinositide 3-kinase; PIP2, phosphatidylinositol (4,5)-bisphosphate; and
PIP3, phosphatidylinositol (3,4,5)-trisphosphate

3.5

Conclusion
In summary, DFP-alone exposure causes significant increases in phosphorylation of

several proteins involved in the MAPK (p-JNK, p-MEK1/2, p-CREB, p-RPS6) pathway in two
brain regions, cortex and hippocampus. Conversely, CORT appears to be partially protective of
the inhibition caused by DFP exposure, but leads to significant decreases in p-SRC that
corresponds to decreases in p-SYK and p-JNK, but increases in p-AKT and p-BAD. The link
between these phosphoprotein targets could be important to further understand how CORT could
be involved in activating a currently unknown independent pathway that may lead to survival, but
potentially result in delayed OP associated diseases. These phosphoprotein pathways should be
further investigated to better understand the long-term protective ability of CORT and the
differentiation between the DFP and CORT+DFP exposures. Additionally, future research relating
these early intracellular responses to long-term effects of disease progression needs to be
performed.
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Chapter 4: Corticosterone and chlorpyrifos oxon exposure elicits spatiotemporal MAPK
phosphoprotein signaling in a mouse brain
Parts of this chapter have been published previously: Julia A. Penatzer, Nicole Prince, Julie V. Miller, Mackenzie
Newman, Cayla Lynch, Gerald R. Hobbs, Jonathan W. Boyd (2021) Corticosterone and chlorpyrifos oxon exposure
elicits spatiotemporal MAPK phosphoprotein signaling in a mouse brain. Food and Chemical Toxicology, 155,
112421. https://doi.org/10.1016/j.fct.2021.112421

Chlorpyrifos (CPF) is one of the most widely-used organophosphate pesticides globally
for agricultural purposes. Certain occupations (e.g., field workers, farmers) are at an increased risk
for high-dose exposure to CPF, which can lead to seizures and irreversible brain injury. Workers
within these occupations also experience increased circulating cortisol levels, which is related to
physiological stress. To better represent this exposure scenario, a mouse model utilized exogenous
administration of corticosterone (CORT; high physiologic stress mimic) in combination with
chlorpyrifos oxon (CPO; oxon metabolite of CPF); this combination increases neuroinflammation
and acetylcholine post-exposure. In the present study adult male C57BL/6J mice were given
CORT (200 μg/mL) in drinking water for seven days followed by a single intraperitoneal injection
of CPO (8.0 mg/kg) on day eight, and euthanized 0.5, 2, and 24 h post-injection. Ten posttranslationally modified proteins were measured in the cortex and striatum to evaluate brain
region-specific effects. The spatiotemporal response to CORT+CPO sequentially activated
phosphoproteins (p-ERK1/2, p-MEK1/2, p-JNK) involved in mitogen-activated protein kinase
(MAPK) signaling. Observed p-ZAP70 responses further integrated MAPK signaling and
provided a spatiotemporal connection between protein phosphorylation and neuroinflammation.
This study provides insight into the spatiotemporal cellular signaling cascade following
CORT+CPO exposure that better represent these vulnerable populations.
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4.1 Introduction
Chlorpyrifos (CPF) is one of the most widely used organophosphate insecticides, and
approximately eight million pounds are applied annually to both agricultural (e.g., corn, soybeans,
cotton, grain) and non-agricultural areas (e.g., golf courses, green houses) in the United States
alone [1-3]. CPF is effective in eliminating pests, but poses serious human health risks [4-5]. Mild
exposures can result in headaches, blurry vision, salivation, and muscle weakness, while highlevel exposures can lead to difficulty breathing, convulsions, irregular heartbeat, coma, and even
death [6]. Prolonged exposure to CPF has been linked to chronic diseases (e.g., cancer,
neurological disorders) and persistent neuroinflammation [7-9]. Despite the toxicity associated
with CPF, its use in agricultural applications has increased worldwide because of its low cost and
easy access [10], which poses a concern for the wellbeing of agricultural workers. Approximately
25% of the world’s population works in an agriculturally related field, which is predominated by
individuals in lower socioeconomic classes [11-12]. These individuals are vulnerable to
malnutrition and high levels of stress, both of which increase circulating cortisol [12-18]. However,
few studies have addressed the mixed exposure profile of high physiological stress with CPF to
better model vulnerable populations that are at an increased risk for exposure in combination with
increased and prolonged cortisol levels.
In order to better understand the combinatorial exposure of CPF and stress, Locker et al.
(2017) developed a mouse model involving pre-treatment with the rodent surrogate for cortisol,
corticosterone (CORT), to mimic a high stress environment, followed by exposure to chlorpyrifos
oxon (CPO), the active metabolite of CPF that inhibits acetylcholinesterase (AChE) [7]. This
combination of CORT+CPO enhanced neuroinflammation; levels of cytokines and chemokines
were higher within the first six hours in the cortex and striatum when compared to controls (CPO
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or CORT alone) [7, 19]. Miller et al. (2018), used the same model to display spatial differences in
acetylcholine concentrations and found that CORT+CPO led to significant increases in the
striatum, but no significant differences in the cortex [19]. However, several studies have suggested
the toxicity associated with CPF is independent of AChE inhibition, but leads to multiple cellular
signaling cascades that promotes apoptosis [20-23].
Previous research has shown increases in brain STAT3 phosphorylation relative to controls
following CORT+CPO exposure [7]. STAT3 is crucial to the Janus kinases/signal transducers and
activators of transcription (JAK/STAT) pathway, which is activated by numerous cytokines, but
also impacts several downstream signaling cascades (e.g., mitogen-activated protein kinase;
MAPKs) known to integrate cellular stress responses [24-25]. To build upon this previous work,
this study investigated key post-translational modifications involved in these pathways to elucidate
the cellular response mechanisms relevant to CPF exposure with stress. By specifically monitoring
early phosphorylation events in the context of previous cytokine and acetylcholine data in the brain,
we aim to disentangle the toxic mechanisms associated with neuroinflammation caused by
hormones (i.e., CORT in this model) from those associated with organophosphate pesticide
exposures (i.e., CPO in this model). In this study, adult male C57BL/6J mice were exposed to
CORT (200 μg/mL) in drinking water for seven days, then given a single intraperitoneal (i.p.)
injection of CPO (8.0 mg/kg) on day eight. Mice were euthanized at 0.5, 2, and 24 h post-exposure
via focused microwave irradiation to preserve the steady-state levels of protein phosphorylation
[26]. To fully understand the effects of CORT+CPO on specific regions of the brain, 10 posttranslationally modified protein targets involved in MAPK signaling were measured using a
multiplex bead-based enzyme-linked immunosorbent assay (ELISA) for the cortex and striatum.
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This approach provided insight to the effects observed post-high stress and pesticide exposure
based on the elucidation of relevant spatiotemporal phosphorylation responses.
4.2 Materials and methods
4.2.1 Animals
All procedures were performed under protocols approved by the Institutional Animal Care
and Use Committee of the Centers for Disease Control and Prevention, National Institute for
Occupational Safety and Health and the Animal Care and Use Review Office from the Department
of Defense. The animal facility was certified by the American Association for Accreditation of
Laboratory Animal Care. Adult male C57BL/6J mice (approximately 8-12 weeks of age) were
purchased from Jackson Laboratory (Bar Harbor, ME, USA) and were individually housed in a
temperature (21 ± 1°C) and humidity-controlled (50 ± 10%) colony room that was maintained
under filtered positive-pressure ventilation on a 12 h light/12 h dark cycle. Mice were given ad
libitum access to food and water.
4.2.2 Dosing
Mice (n=at least five/group) received CORT (Steraloids Inc., Newport, RI, USA) in the
drinking water (200 μg/mL in 1.2% ethanol, Sigma-Aldrich Co.) for seven days (Figure 4.1) based
on previous research shown to achieve high circulating levels of the hormone [27-28]. Control
groups received 1.2% ethanol in the drinking water. On day eight, mice received a single i.p.
injection of peanut oil or CPO (8.0 mg/kg, Chem Service, Inc., West Chester, PA, USA; Figure
4.1), which produced symptoms of cholinergic crisis (e.g., SLUD [salivation, lacrimation,
urination, and defecation] and seizures) while displaying mortality below LD25, in accordance
with Locker et al. (2017) [7]. CPO (the oxon metabolite of CPF) was used in place of CPF to avoid
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animal variability related to the bioactivation of CPF, in line with previous research [29-30]. Mice
were then returned to their home cage prior to sacrifice.
Preliminary power analyses (α = 0.05) revealed that an N=4 was sufficient for this study
to determine phosphoprotein significant differences between exposure groups. Following exposure,
peanut oil (N=5), CORT (N=5), and CPO (N=7) exposed mice survived all of the time points, but
only 5 of 7 mice from the CORT+CPO exposure survived at the 2 h and 24 h time points (71%
survival rate). Mice that did not survive to study termination were excluded from analysis.

Figure 4.1. Dosing paradigm for corticosterone and chlorpyrifos oxon exposure. Timeline for administration of
chlorpyrifos oxon (CPO 8.0 mg/kg) after corticosterone (CORT) priming (200 μg/mL in 1.2% ethanol) in drinking
water.

4.2.3 Brain dissection
Mice were sacrificed at three time points (0.5, 2, and 24 h post-exposure) by focused
microwave irradiation to preserve the steady-state levels of protein phosphorylation and provide a
snapshot of the cell signaling alterations in response to these exposures [26]. Whole brains were
removed from the skull and dissected free-hand with fine-curved forceps on a thermoelectric cold
plate (Model TCP-2; Aldrich Chemical Co., Milwaukee WI) into the cortex and striatum. The
cortex and striatum were chosen based on previous cytokine and acetylcholine data determined
from this model [7, 19]. The striatum has a higher density of acetylcholine and AChE than the
cortex, which may have discrete brain-region differences in the resulting phosphoprotein signaling
[31-33]. Samples were immediately rinsed with ice cold phosphate buffered saline, snap frozen,
and stored at -80°C until analysis
85

4.2.4 Protein quantification
Methods from Hulse et al. (2004) were adapted for protein extraction [34]. Specifically,
one side of each brain region (e.g., left cortex) was placed into a tube with 500 μL of Bio-Rad cell
lysis buffer containing a protease inhibitor cocktail (Bio-Rad Factor 1 and 2; Bio-Rad, Hercules,
CA) and 2 mM phenylmethylsulfonyl fluoride (Sigma, St. Louis, MO). Samples were
homogenized on ice with three rapid pulses for three seconds at 35% amplitude (Fisher Scientific,
Pittsburgh, PA). Samples were centrifuged at 4,500 x g for 4 min at 4°C, and then the supernatant
was collected into a sterile tube and stored at -80°C. Total protein concentration was determined
using the Pierce protein assay (Fisher Scientific, Pittsburgh, PA), according to the manufacturer’s
instructions. Absorbance values were determined at 562 nm using an Infinite M1000 plate reader
(Tecan, Raleigh, NC).
4.2.5 Phosphoprotein analysis in discrete brain regions
For phosphoprotein analysis, sample homogenates were diluted to a total protein
concentration of 700 μg/mL with sample diluent (Bio-Rad, Hercules, CA). Samples were assayed
using a custom Bio-Plex Pro multiplexed magnetic bead-based immunoassay reagent kit for the
following phosphorylated targets at the indicated amino acid residues: p-BAD (S136), p-p70 S6
Kinase (T389; p-p70S6K), p-S6 Ribosomal P (S235/S236; p-RPS6), p-ZAP70 (Y319), p-CREB
(S133), p-ERK1/2 (T202/Y204, T185/Y187), p-GSK3α/β (S21/S9), p-IκBα (S32/S36), p-JNK
(T183/Y185), and p-MEK1/2 (S217/S221). All samples were analyzed with a Bio-Plex 200
suspension array system and Pro II Wash Station (Bio-Rad, Hercules, CA), according to the
manufacturer’s instructions. Biological replicates were at least in quadruplicate and all
measurements were performed in duplicate (technical replicates). Bio-Rad lysate positive (EGFtreated HEK-293, UV-treated HEK-293, EGF-treated SK-BR-3, TNF-α-treated HeLa, NGF-β-
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treated PC12, H2O2-treated Jurkat, and PDGF-treated NIH3T3) and negative (phosphatase-treated
HeLa) controls were used to ensure appropriate bead counts.
4.2.6 Statistical analysis
All data analyses were performed using GraphPad Prism (V5; San Diego, CA, USA).
Averaged raw values were blank-subtracted and any targets which showed a negative
phosphorylation response (target < blank) were removed before analysis. Relative phosphorylation
was determined for each target by normalizing to the peanut oil controls. A Grubbs’ test was
performed to remove any significant outliers (α = 0.05). As previously mentioned, any nonsurviving animals were also excluded from analysis. The normalized phosphorylation ± the
standard error of the mean (SEM) for each exposure and time point was used to identify significant
targets. Two-way analysis of variance (ANOVA) with Bonferroni post-tests were performed to
determine significance (p<0.05).
4.3

Results

4.3.1 Relative phosphorylation responses in the cortex
In the cortex, CORT+CPO exposure elicited a significant response (p<0.05) for all
measured phosphoproteins compared to the controls for at least one time point (Figure 4.2).
CORT+CPO caused a significant (p<0.05) increase in phosphorylation of RPS6 at 0.5 h postexposure relative to CORT alone. At 2 h, CORT+CPO resulted in significantly (p<0.05) increased
phosphorylation of p-p70S6K compared to CORT alone. Phosphorylated CREB, ERK1/2,
GSK3α/β, IκBα, and MEK1/2 were also significantly (p<0.05) increased for CORT+CPO relative
to CPO alone (Figure 4.2). Conversely, at 24 h, p-ERK1/2 was significantly (p<0.05) decreased
for CORT+CPO compared to peanut oil, while p-BAD and p-MEK1/2 were significantly (p<0.05)
decreased in response to CORT+CPO relative to all of the controls: peanut oil, CORT, and CPO
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(Figure 4.2). At 24 h, p-JNK and p-ZAP70 were significantly (p<0.05) increased post-CORT+CPO
exposure (Figure 4.2).
Temporally, several phosphoproteins were significantly (p<0.05) increased in response to
CORT+CPO or CORT alone at 2 h or 24 h post-exposure (Figure 4.2). CORT+CPO resulted in
significant (p<0.05) increases at 2 h relative to 24 h for p-p70S6K and p-GSK3α/β. Similarly, pCREB, p-ERK1/2, and p-MEK1/2 were significantly (p<0.05) increased for CORT+CPO
exposure at 2 h relative to 0.5 and 24 h (Figure 4.2). Phosphorylated BAD and IκBα were
significantly (p<0.05) decreased at 24 h compared to the early time points following CORT+CPO
exposure, whereas JNK was significantly (p<0.05) phosphorylated (Figure 4.2). CORT alone also
resulted in a significant (p<0.05) increase at the 2 h time point for p-ERK1/2.
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Figure 4.2. Significant phosphoprotein responses in the cortex via multiplex ELISA post-exposure to corticosterone
and chlorpyrifos oxon. Mice were exposed to control or 200 μg/mL CORT in drinking water for seven days. On day
eight, mice were given a single injection of CPO (8 mg/kg, i.p.) or peanut oil (Figure 4.1) and sacrificed via focused
microwave irradiation at 0.5, 2, or 24 h post-exposure. Data are represented as mean ± SEM with at least N=4 for all
phosphoproteins. Two-way ANOVA with Bonferroni post-test was used for determining significance, where @
indicates a significant difference (p<0.05) between 0.5 h vs. 2 h, # indicates a significant difference (p<0.05) between
0.5 h vs. 24 h, and % indicates a significant difference (p<0.05) between 2 h vs. 24 h for a particular exposure.
Horizontal bars represent significance (p<0.05) between exposures within a specific time.

4.3.2 Relative phosphorylation responses in the striatum
The striatum only had two phosphoproteins that were significantly (p<0.05) affected by an
exposure (Figure 4.3). Phosphorylated BAD was significantly (p<0.05) decreased for CORT+CPO
exposure at 0.5 h relative to peanut oil and CPO (Figure 4.3). Similar to the cortex, CORT+CPO
resulted in a significant (p<0.05) increase in phosphorylation of p-JNK at 24 h (Figure 4.3) relative
to peanut oil and CORT alone.
Temporally, CORT+CPO exposure significantly (p<0.05) increased MEK1/2 (p<0.05)
phosphorylation at 0.5 h relative to 24 h. At 2 h, p-BAD was significantly increased (p<0.05) for
CORT+CPO compared to 0.5 and 24 h post-exposure (Figure 4.3). Phosphorylated ZAP70 and
JNK were both significantly (p<0.05) increased at 24 h post-exposure for CORT+CPO (Figure
4.3). CORT alone significantly (p<0.05) increased p-p70S6K at the 24 h time point (Figure 4.3).
CPO alone also led to significant (p<0.05) changes in phosphoprotein responses in the striatum:
p-MEK1/2 and p-BAD were significantly (p<0.05) decreased at 24 h relative to 0.5 h and 2 h,
respectively, while p-p70S6K was significantly (p<0.05) increased at 24 h post-exposure
compared to 2 h (Figure 4.3).
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Figure 4.3. Significant phosphoprotein responses in the striatum via multiplex ELISA post-exposure to corticosterone
and chlorpyrifos oxon. Mice were treated with the same dosing regimen and sacrifice as stated in Figure 4.1. Twoway ANOVA with Bonferroni post-test were used for determining significance, where the horizontal bars represent
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(p<0.05) between 0.5 h vs. 2 h, # indicates a significant difference (p<0.05) between 0.5 h vs. 24 h, and % indicates a
significant difference (p<0.05) between 2 h vs. 24 h for a particular exposure. Data are represented as mean ± SEM.

4.4

Discussion
CPF remains in the top 15 of the most-widely used pesticides worldwide, but presents

serious health risks, especially to those employed in agriculture [35-37]. As such, numerous studies
point to the detrimental effects of CPF alone. To better represent the vulnerable populations in
agriculture who are most likely to be exposed to high concentrations of CPF and carry the burden
of chronically increased cortisol, this combinatorial exposure scenario should be further explored
[12-18].

Previous

rodent

studies

using

CORT+CPO

exposure

found

increases

in

neuroinflammation post-exposure [7, 19]. Thus, an investigation into early intracellular signaling
responses via protein phosphorylation in discrete brain regions (i.e., cortex and striatum) was
performed to discern the pathways that may reveal biomolecular drivers of neuroinflammation and
toxicity associated with this exposure scenario involving a susceptible population.
Early cellular post-translational phosphorylation events regulate adaptive stress and
inflammatory pathways that are dependent on both spatial location and time to initiate the
appropriate cell signaling cascades [38-40]. By analyzing discrete tissue regions, we were able to
discriminate local xenobiotic toxicity that may otherwise go undetected in pooled brain samples
[31]. Moreover, the temporal response from the phosphoproteins tested in this study provided
valuable insight into the changes in MAPK signaling cascades at earlier time points (0.5 and 2 h
post-exposure) versus the delayed phosphoprotein response (24 h). In the cortex, at the early time
points post-exposure to CORT+CPO, there were significant (p<0.05) increases in the
phosphorylation of proteins in the MEK/ERK cascade: p-RPS6 was significantly increased at 0.5
h, while p-MEK1/2, p-ERK1/2, p-p70S6K, and p-CREB are all significantly increased at 2 h for
CORT+CPO relative to the controls (Figure 4.2). This cascade couples’ signals from cell-surface
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cytokine (e.g., interleukin (IL)-3, granulocyte/macrophage colony stimulating factor [GM-CSF])
receptors to key downstream pathways involved in cell proliferation and differentiation [41-42].
These cytokines trigger the phosphorylation of MEK1/2 and ERK1/2, which, in turn, have been
shown to phosphorylate p70S6K, RPS6, and CREB (Figure 4.4) [43-45]. Previous research has
implicated the MEK/ERK cascade in vitro following CPF or CPO exposure alone, in agreement
with the present study [20-21, 46-48].

Figure 4.4. MAPK signaling pathway following corticosterone with chlorpyrifos oxon exposure. Activation of the Tcell receptor (TCR) increases activity of ZAP70, which promotes activation of the MAPK pathway (i.e., JNK,
MEK/ERK). The MEK/ERK pathway can also be stimulated by GM-CSF and IL-3. Activation of this pathway results
in phosphorylation of MEK1/2 and ERK1/2, which, in turn, phosphorylate p70S6K, RPS6, and CREB promoting cell
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proliferation and differentiation. In contrast, JNK phosphorylation eventually results in cell death. JNKs can also be
activated by IL-1 and TNF-α. The solid lines represent a direct effect on phosphorylation between proteins, whereas
the dotted line indicates an indirect connection

By continuing to monitor the post-exposure time course to 24 h, we can further evaluate
how previously-reported cytokine responses (e.g., tumor necrosis factor-α (TNF-α), interleukin
(IL)-1) from 6 h post-exposure to CORT+CPO alter the intracellular signaling response [7, 19].
Our results demonstrated a shift in MAPK signaling in the cortex at 24 h post-exposure to
CORT+CPO; p-JNK is activated in response to CORT+CPO at the later time point concurrent
with MEK/ERK phosphorylation decreases (Figure 4.2). Phosphorylated JNK is also significantly
increased in the striatum to CORT+CPO exposure at 24 h (Figure 4.3). The JNK pathway is
activated by environmental stressors and inflammatory cytokines (e.g., TNF-α, IL-1) and has been
shown to have a central role in apoptosis (Figure 4.4) [48-51]. Therefore, these increases in TNFα and IL-1 in the cortex and striatum may be leading to the activation of p-JNK observed in the
present study.
In a study by Lazar et al. (2016), exposure to sarin, which is an irreversible AChE inhibitor,
resulted in a temporary increase in ERK1/2, but saw no differences with JNK response in a rat’s
cortex; however, at 24 h, ERK1/2 was decreased and JNK was increased, similar to the present
study (Figure 4.2) [52]. Moreover, JNKs have been implicated in several studies post-exposure to
CPF or CPO to initiate apoptosis, which may lead to the development of neurodegenerative
disorders [20-21, 53-54]. Interestingly, inhibition or decreases in p-ERK1/2 post-exposure to CPF
has also been linked to delayed neurotoxicity [55]. These MAPK signaling related significant
phosphoprotein findings have also been demonstrated with CPO or CPF alone, but, in the present
study, there were no significant differences with CPO alone (Figures 4.2, 4.3). However,
CORT+CPO initiates these pathways, indicating that CPO exposure with CORT priming is more
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sensitive to neuroinflammation and results in activation of this apoptotic pathway. Therefore, in
the work presented here, the initial response to CORT+CPO may inhibit apoptosis (e.g., increased
p-ERK1/2, p-MEK1/2), but by 24 h this phosphoprotein signaling is indicative of cell death (e.g.,
decreased p-ERK1/2 and increased p-JNK).
To further evaluate the relationship between neuroinflammation, immune responses,
MAPK signaling, and CORT+CPO exposure p-ZAP70 was measured. ZAP70 plays a crucial role
in regulating downstream signaling events involved in MAPK pathways (Figure 4.4), and is linked
to the release of inflammatory mediators (e.g., TNF-α, IL-6), protein tyrosine phosphorylation,
and activation of T cells as phosphorylation is required in order to initiate T cell signaling [56-61].
In the present study, p-ZAP70 was found to be significantly (p<0.05) increased at 24 h postexposure to CORT+CPO in the cortex (Figure 4.2) and the striatum (Figure 4.3). Therefore,
ZAP70 provides an interesting link to previously observed inflammation through T cell signaling
and the activation of JNK.
4.5

Conclusion
In summary, a mouse model was used to investigate the early cellular signaling cascade

post-exposure to CORT and CPO to better represent the exposure scenario associated with a
vulnerable population with chronically elevated cortisol who are exposed to CPF. Within this study
it was determined that CORT+CPO initiates distinct spatiotemporal phosphoprotein signaling
responses. The cortex appears to be sequentially activating phosphoproteins involved in MAPK
signaling: the MEK/ERK cascade is first phosphorylated in response to this combined exposure,
but at 24 h these phosphoproteins are decreased. Phosphorylated JNK is increased at 24 h for both
brain region regions, suggesting the initiation of cell death via apoptosis. ZAP-70, which functions
upstream of MAPK signaling, provides an interesting biomarker in regard to the connection
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between CORT+CPO exposure and neuroinflammation via T-cell stimulation, which may be
related to the increased toxicity observed in response to the combination of both exogenous (i.e.,
CPO) and endogenous (i.e., CORT) stressors. Future studies will further probe these proteins and
their post-translational modifications at later time points and different doses of CPO to better
understand the long-term effects associated with this exposure scenario involving a vulnerable
population.
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Chapter 5: Differential phosphoprotein signaling in the cortex in mouse models of Gulf War
Illness using corticosterone and acetylcholinesterase inhibitors
Parts of this chapter have been published previously: Julia A. Penatzer, Julie V. Miller, Nicole Prince, Misa Shaw,
Cayla Lynch, Mackenzie Newman, Gerald R. Hobbs, Jonathan W. Boyd (2021) Differential phosphoprotein signaling
in the cortex in mouse models of Gulf War Illness using corticosterone and acetylcholinesterase inhibitors. Heliyon,
7, e07552. https://doi.org/10.1016/j.heliyon.2021.e07552

Veterans from the 1990-91 Gulf War were exposed to organophosphate (OP) acetylcholinesterase
inhibitors (AChEIs), and, following service, an estimated one-third began suffering from a
medically unexplained, multi-symptom illness termed Gulf War Illness (GWI). However, even 30
years after deployment, these veterans continue to suffer from this symptomology and neither the
exact etiology, nor a cure has been found. The work presented in the previous two chapters of this
dissertation introduce two OP AChEIs, with and without corticosterone (CORT) exposure, that
have been validated for this specific disease state of GWI. To further elucidate the mechanisms
associated with these mouse models and how they relate to the diverse symptomology of GWI, a
deeper investigation into these intracellular responses in the cortex were performed to characterize
the early cellular signaling changes associated with this exposure-initiated neuroinflammation.
Eleven of the post-translationally modified protein targets from Chapters 3 and 4 were chosen to
be further examined. Phosphoprotein responses were found to be exposure specific following
AChEI insult, with and without CORT. Specifically, a 3-way interaction displayed a significant
interaction (cross) between CORT and AChEI for p-BAD, p-RPS6, p-SRC, p-SYK, and p-JNK
(Table 3), indicating that this subset of phosphoproteins play an important role in differentiating
between all four exposures. Ingenuity Pathway Analysis further presented the divergence between
all exposure groups, especially at the later time points (2 and 24 h post-exposure). The results of
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this study provide insight into differentially activated pathways depending on AChEI in these GWI
models.
5.1

Introduction
Gulf War Illness (GWI) is a chronic, multi-symptom disorder that has afflicted veterans of

the 1990-91 Persian Gulf War (GW) since they left theater. Approximately 30% of deployed
veterans exhibit a variety of symptoms including cognitive and memory impairments, depression,
and gastrointestinal disorders [1-7]. The symptoms are consistent with features of “sickness
behavior,” the basis of which is elaboration of inflammatory mediators in the brain, i.e.,
neuroinflammation [8-9]. Studies have demonstrated that neuroinflammation is common among
GW veterans, and is not confounded by sex, age, or body mass index [10-13], leading to a
consensus that neuroinflammation is a hallmark of GWI [7-8].
The exact etiology of GWI remains unknown, but the Research Advisory Committee on Gulf
War Veterans’ Illnesses concluded that exposure to acetylcholinesterase inhibitors (AChEIs) are
the most likely cause of the symptoms of GWI [14-15]; these AChEI exposures include the
chemical warfare agent sarin [16], or pesticides, such as chlorpyrifos [17]. Veterans were also
exposed to a variety of mental/physical stressors in theater [18]. Therefore, O’Callaghan et al.
(2015), established a GWI mouse model using corticosterone (CORT; the rodent surrogate for
cortisol) pre-treatment at levels that would be associated with high stress in combination with
either diisopropyl fluorophosphate (DFP; sarin surrogate) or chlorpyrifos oxon (CPO; oxon
metabolite of chlorpyrifos) [1-2]; these models resulted in marked neuroinflammation
characterized as increases in a panel of cytokines and chemokines measured by qPCR. In an effort
to elucidate the underlying mechanisms for these observations, Miller et al. (2018), measured
acetylcholine concentrations for each model and found that acetylcholinesterase (AChE) inhibition
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is compound specific when pretreated with CORT: CORT ameliorated acetylcholine increase
induced by exposure to DFP, but inhibition caused by CPO was not ameliorated by CORT priming
[19]. However, both models still resulted in inflammation suggesting an AChE-independent
pathway may be the driving force behind the exacerbated neuroinflammation [19].
Cytokine-initiated inflammation, like that observed with these models of neuroinflammation
[1-2], directly initiates cellular signaling changes in impacted tissues, which can be measured
through post-translational modifications (e.g., protein phosphorylation) at early time points postexposure [20-21]. Protein phosphorylation is vital to the coordination of cellular functions and
leads to a cascade of cellular signals; however, abnormal or prolonged phosphorylations can lead
to dysregulation of signaling pathways, which is the basis of a number of disease states [22-26].
This study was conducted to distinguish key phosphorylation events that are involved in these
pathways to better elucidate the cellular response mechanisms relevant to these acute exposure
models of GWI. Moreover, this study was performed to probe the differences in the signaling
cascades for these AChEIs, with and without CORT. Using this knowledge, we attempt to
understand how these responses ultimately lead to the diverse symptomology of GWI.
In this study, adult male C57BL/6J mice were exposed to CORT (200 μg/mL) in the drinking
water for seven days, and given a single intraperitoneal (i.p.) injection of either DFP (4.0 mg/kg)
or CPO (8.0 mg/kg) on the eighth day. Mice were euthanized at 0.5, 2, and 24 h post-exposure,
and 11 post-translational modifications protein targets were measured in the cortex to understand
the temporality of phosphoprotein responses in these validated mouse models of GWI.
5.2

Materials and methods

5.2.1 Data description
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Relative phosphoprotein concentrations were measured after exposure to DFP or CPO as
described in chapters 3 and 4, respectively. Briefly, mice received CORT in the drinking water
(200 μg/mL in 1.2% ethanol) for seven days prior to exposure. Control groups received 1.2%
ethanol water. On day eight, mice were given a single i.p. injection of saline (0.9%), peanut oil
(CPO vehicle), DFP (4.0 mg/kg), or CPO (8.0 mg/kg) in the morning and returned to their home
cage. Mice were euthanized at three time points (0.5, 2, and 24 h post-exposure) by focused
microwave irradiation to provide a snapshot of the early cell signaling alterations that result in
long-term impacts using a high-throughput approach. All procedures were performed under
protocols approved by the Institutional Animal Care and Use Committee of the Centers for Disease
Control and Prevention, National Institute for Occupational Safety and Health, and the animal
facility was certified by the American Association for Accreditation of Laboratory Animal Care.
Samples were assayed using the Bio-Plex Pro multiplexed magnetic bead-based
immunoassay reagent kit for the following 11 targets phosphorylated at the indicated amino acid
residues: p-BAD (S136), p-S6 Ribosomal P (S235/S236; p-RPS6), p-SRC (Y416), p-SYK (Y352),
p-CREB (S133), p-ERK1/2 (T202/Y204, T185/Y187), p-GSK3α/β (S21/S9), p-IκBα (S32/S36),
p-JNK (T183/Y185), p-MEK1/2 (S217/S221), and p-p90RSK (S380). Samples were analyzed
using a Bio-Plex 200 suspension array system and Pro II Wash Station (Bio-Rad), according to the
manufacturer’s instructions.
5.2.2 Data processing
Relative phosphorylation was determined for each target. The averaged raw values were
blank-subtracted, and any phosphoprotein non-detects (response was less than blank) were
removed before analysis. The blank-subtracted values were then normalized to the respective
controls (saline for DFP, peanut oil for CPO) at each time point. A Grubbs’ test was performed to
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remove any significant outliers (α = 0.05). As previously mentioned, any non-surviving animals
were also excluded from analysis. Thus, these analyses resulted in at least N=4 animals for all
phosphoproteins. Data analyses were performed using GraphPad Prism (V5; San Diego, CA, USA)
or SAS JMP (V14; Cary, NC, USA). The normalized phosphorylation ± the standard error of the
mean (SEM) for each exposure and time point were used to identify significant targets.
5.2.3 3-way interaction
A 3-way interaction was conducted using SAS JMP to determine the main effects and
interactions for each phosphoprotein [27]. The factors for the 3-way interaction were time (0.5, 2,
24 h), and exposure (CORT effect or AChEI effect). A threshold of p<0.05 was chosen, and a
Bonferroni correction (for the seven tests) was applied to omit a type I error [28-29], resulting in
a significance level of p<0.007 representing findings that were statistically significant. A 3-way
interaction splits the exposures into binary effects of CORT (CORT+DFP and CORT+CPO versus
DFP and CPO alone) or AChEI (CPO alone and CORT+CPO versus DFP alone and CORT+DFP),
which allows for differences to be easily detected between groups. Cube plots were used to
understand the nature of the relationships between the 3-way interactions [30].
5.2.4 Ingenuity Pathway Analysis (IPA)
The relative phosphorylation responses were further evaluated using QIAGEN’s Ingenuity
Pathway Analysis (IPA; Redwood City, CA, USA) to understand the network and cellular pathway
interactions of the selected phosphoproteins. The proposed networks were generated for all three
time points (0.5, 2, and 24 h) following each AChEI exposure with and without CORT (DFP, CPO,
CORT+DFP, CORT+CPO). All of the networks were comprised of the experimental dataset in
addition to other projected nodes likely to be involved in the network based on the observations
from the experimental dataset and Ingenuity’s knowledge base. IPA also assigned a p-score
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(negative log10 (p-value of Fisher’s exact test)) to each of the networks. For more information
refer

to

Ingenuity’s

Analysis

(http://pages.ingenuity.com/rs/ingenuity/images/0812%20upstream_regulator_analysis_whitepap
er.pdf).

5.3

Results
A panel of phosphoproteins involved in regulatory stress and inflammatory pathways

associated with early responses of neuroinflammation were assayed via multiplex bead-based
ELISA. The phosphoprotein responses were normalized to controls (saline or peanut oil for DFP
and CPO, respectively) in the cortex at 0.5, 2, and 24 h post-exposure. As previously mentioned,
the DFP-exposure cohort resulted in all saline (N=5), CORT alone (N=5), and CORT+DFP (N=7)
exposed mice surviving at the 24 h time point, but only 5 of 14 mice from the DFP exposure alone
group surviving (36% survival rate). Conversely, for the CPO exposure cohort: all of the peanut
oil (N=5), CORT (N=5), and CPO (N=7) exposed mice survived all the time points, but only 5 of
7 mice from the CORT+CPO exposure survived at the 2 h and 24 h time points (71% survival
rate).
5.3.1 3-way interactions revealed distinct phosphorylation responses
To explore the potential interactions between CORT and AChEIs and how time may affect
these interactions, a 3-way interaction was performed on all of the phosphoprotein targets. A 3way interaction allows us to further determine if the significant effects associated with each target
are driven by the different exposures (AChEI or CORT), time, or both. The factors tested were
time (0.5, 2, 24 h), and exposure (CORT effect or AChEI effect), and a level of p<0.007 was used
to determine significance after a Bonferroni correction. The 3-way interaction revealed p-RPS6,
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p-CREB, p-ERK1/2, p-IκBα, and p-JNK all were significant for time alone, demonstrating the
importance of monitoring the phosphoprotein responses over time (Table 5.1).
Table 5.1. 3-way interaction revealed distinct phosphoprotein responses in mouse models of Gulf War Illness. A 3way interaction was conducted using SAS JMP to determine significant interactions for all 11 phosphoproteins. The
factors were time (0.5, 2, 24 h) and exposure (CORT effect or AChEI effect). A significance level of p<0.007 was
used to determine statistical significance. Only interactions with statistical significance are shown for each
phosphoprotein. A “x” is used to display a cross between two factors.

Phosphoprotein

Interaction

p-value

CORT x AChEI

0.00007

CORT

0.00010

Time

0.00545

Time

0.00066

CORT x AChEI

0.00498

Time x AChEI

0.00001

CORT x AChEI

0.00021

AChEI

0.00379

Time x CORT x AChEI

0.00642

p-SYK (Y352)

CORT x AChEI

0.00247

p-CREB (S133)

Time

0.00058

Time

0.00000

p-BAD (S136)

p-RPS6 (S235/S236)

p-SRC (Y416)

p-ERK1/2
T185/Y187)

(T202/Y204, AChEI

0.00000

Time x AChEI

0.00001

Time x CORT

0.00017
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AChEI

0.00004

CORT

0.00117

Time

0.00006

Time x CORT x AChEI

0.00109

Time

0.00440

p-GSK3α/β (S21/S9)
p-IκBα (S32/S36)

p-JNK (T183/Y185)

Of the 11 phosphoproteins tested, 6 of the targets (p-BAD, p-RPS6, p-SRC, p-SYK, pERK1/2, and p-GSK3α/β) displayed a significant (p<0.007) interaction between CORT, AChEI,
or the cross (CORT x AChEI) (Table 5.1). A significant interaction for CORT represents a
difference between the primed with CORT AChEI exposures (CORT+DFP, CORT+CPO) versus
those without CORT (DFP, CPO). A significant AChEI interaction differentiates between the
AChEI exposures regardless of CORT (CORT+DFP and DFP versus CORT+CPO and CPO). Our
results indicate p-BAD and p-GSK3α/β were significant for the CORT effect demonstrating a
significant difference (p<0.007) between the CORT primed exposures (i.e., CORT+DFP and
CORT+CPO) from the AChEIs alone (DFP and CPO) (Table 5.1). The significant CORT
interaction provides further evidence of how the mixtures of CORT+AChEIs impact the
phosphorylation of specific proteins, and therefore distinguishes from the pathways that are
affected by AChEIs alone. Phosphorylated SRC, ERK1/2, and GSK3α/β were significant (p<0.007)
for the AChEI interaction, which indicates these specific phosphoproteins are important to
differentiate between the inhibitor exposures regardless of the addition of CORT. A significant
cross (p<0.007) between CORT and AChEI was observed for p-BAD, p-RPS6, p-SRC, and pSYK (Table 5.1), indicating there was a significant difference between each of the exposures and
both interactions attribute to the differences between the four exposures (DFP, CORT+DFP, CPO,
109

CORT+CPO). Thus, these phosphoproteins may be good indicators to differentiate between all the
exposures. Phosphorylated JNK and SRC demonstrated a significant cross (p<0.007) between all
factors (Time x CORT x AChEI) (Table 5.1; Figure 5.1), displaying that both p-SRC and p-JNK
can also differentiate between all the exposures, but in a time dependent manner.

Figure 5.1. Cube plots for p-SRC (Y416) and p-JNK (T183/Y185). A 3-way interaction was conducted using SAS
JMP to determine the main effects and interactions for each phosphoprotein. The factors were time (0.5, 2, 24 h) and
exposure (CORT effect or AChEI effect). Cube plots were used to understand the nature of the relationships between
the three-factor interactions. The vertices display the fitted mean of the logarithm transformed data ± standard error.
Only interactions with a statistically significant 3-way cross are shown (p<0.007), where arrows with * represent the
significant differences between the interactions.

5.3.2 Ingenuity Pathway Analysis (IPA) generated networks
IPA was performed to further explore the pathways and biological processes associated
with the tested phosphoprotein responses, while identifying additional nodes of interest for future
studies. The normalized phosphorylation responses measured in this study were used to generate
a network with a total of 35 nodes, 11 of which are from the dataset, but the remaining 24 are
based on connectivity with the dataset and known pathways from literature (Table 5.2;
Supplemental Tables 1-3) [31]. At 0.5 h, over half of the nodes generated were the same regardless
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of exposure (Table 5.2). However, at 2 and 24 h there were only six and four nodes, respectively,
that were similar between exposures demonstrating divergence of these networks at later time
points. Specifically, at 2 h post-exposure to DFP alone, 14 of the generated nodes were not found
in the other networks (Supplemental Table 2). At 24 h, the CORT+DFP network generated 20
unique nodes to that exposure (Supplemental Table 3). Amongst all of the generated networks,
two cytokines, tumor necrosis factor (TNF) and interferon gamma (IFN-γ), a kinase, PDPK1, and
a phosphatase, PTEN, were observed across all of the time points and exposures (Table 5.2).
Therefore, these time-independent common nodes are highly connected to the dataset, and may be
shared links to the observed neuroinflammation with both of these AChEIs [1-2, 19, 32].
Table 5.2: IPA projected nodes. IPA networks were generated from the experimental dataset and the top molecules in
these pathways were reported. The table represents the nodes that were similar across all exposures at each time point.
The network p-score (negative log10 (p-value of Fisher’s exact test)) for all networks was 28.

0.5 h

2h

24 h

TNF, PDPK1, IFN-γ, PTEN,
ALDH1L1, FGR, BTG1, CRK,
TNF, PDPK1, IFN-γ, PTEN,
HAVCR2, RPS6KA3, RASGRF2,
TNF, PDPK1, IFN-γ, PTEN
ALDH1L1, FGR
ATE1,
GPR19,
TRAFD1,
PPP2R1A

5.4

Discussion
A complete understanding of the exposures that led to GWI, as well as viable treatments,

have yet to be determined 30 years after the 1990-91 GW. Previous research suggests that exposure
to AChEIs, such as sarin or pesticides (e.g., chlorpyrifos), are one of the probable causes of GWI
[8, 17, 33]. With this in mind, several rodent models have investigated the role of AChEI exposure,
specifically DFP or CPO, in GWI, and related this to significant neurological effects [34-39]. To
build upon the likely exposure to high stress, and better replicate in-theater conditions, rodent
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models have included exogenous CORT priming in combination with these AChEIs [1-2, 19].
Studies utilizing these rodent models of GWI have demonstrated exacerbated neuroinflammation
in CORT pretreated animals compared to the controls, which has been related to the sickness
behavior observed in veterans from the GW [1-2]. Conversely, Miller et al. (2018), displayed
differences in AChE inhibition depending on the AChEI (CORT ameliorated acetylcholine
increase caused by DFP, but AChE inhibition caused by CPO was not impacted by CORT) [19].
These results suggest a potential AChE-independent route of GWI-related neuroinflammation. To
better understand the neurological responses associated with these mouse models of GWI, this
study investigated early intracellular signaling responses via phosphoprotein analysis in the cortex.
As previously stated in Chapter 4, our results indicated, CORT+CPO led to significant
increases (p<0.05) in phosphorylation of proteins in the MEK/ERK cascade at the early time points
(0.5 and 2 h) (Figure 4.2). Conversely, at 24 h post-exposure to CORT+CPO, the shift in MAPK
signaling occurs with p-JNK increasing in response to CORT+CPO, while p-MEK1/2 and pERK1/2 phosphorylation decreases (Figure 4.2). Within the present study, the 3-way interaction
analysis showed a significant (p<0.007) response for time alone for several proteins involved in
MAPK signaling (p-RPS6, p-CREB, p-ERK1/2, and p-JNK; Table 5.1), further indicating the
temporal differences in this pathway. All of the temporal responses taken together indicate that
early inflammation associated with CORT+CPO involves MAPK proteins that transition from
MEK/ERK (pro-survival) to JNK (proapoptotic) in less than 24 h post-exposure. Similar to
CORT+CPO, JNK was also significantly phosphorylated (p<0.05) at 24 h following DFP alone
exposure (Figure 3.2), but the combination of CORT+DFP ameliorated this significant
phosphoprotein response as shown in Chapter 3.
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To expand on the differences in phosphoprotein responses observed in the two-way
analysis of variances (ANOVAs) to these AChEIs, with and without CORT, we observed
significant crosses (p<0.007) from the 3-way interaction. Interestingly, p-BAD, p-RPS6, p-SRC,
and p-SYK (Table 5.1; Figure 5.1) all displayed a significant cross between CORT and AChEI,
indicating that this subset phosphoproteins also play an important role in differentiating between
all four exposures (DFP, CPO, CORT+DFP, CORT+CPO). Importantly, these phosphoproteins
connect previous discussions of p-BAD, p-SRC, and p-SYK that have crucial relationships that
link to the MAPK signaling pathways explored in this study [40-41]. Additionally, p-JNK, which
has been extensively discussed throughout this dissertation, displayed a significant cross between
all three factors (Figure 5.1) indicating the ability to differentiate between all four exposures, but
in a time-dependent manner. Previously-reported increases in cytokine responses (e.g., TNF-α, IL1) from 6 h post-exposure to CORT+AChEIs may be leading to the significant differences
associated with p-JNK appear at 24 h post-exposure [2]. Moreover, these significant increases in
p-JNK at 24 h aligns with the animal deaths observed at the 24 h time points for DFP alone and
CORT+CPO. Overall, these proteins give us a framework for a better understanding of the
pathway divergence associated with each exposure and may offer insight into an AChEindependent neuroimmune mechanism of GWI.
IPA was performed to further explore the pathways associated with the tested
phosphoprotein responses. IPA analysis also displayed the divergence between the exposure
groups, especially at the later time points (2 and 24 h post-exposure; Table 5.2). These distinctions
in phosphoprotein responses, depending on AChEI, may be related to the differences Miller et al.
(2018) observed in ACh concentrations and relate to the differences observed in the two-way
ANOVAs [19]. Importantly, IPA analysis also indicated TNF and IFN-γ are common nodes
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between all the exposure networks, independent of time (Table 5.2). Therefore, these timeindependent nodes are highly connected to the dataset, and may be shared links to the observed
neuroinflammation with both of these AChEIs [2, 19, 32].
5.5

Conclusion
Mouse models of GWI were used to explore early cellular signaling changes in the cortex

post-exposure to two AChEIs, with and without CORT. These exposures have been shown to cause
neuroinflammation [1-2], but AChE inhibition was AChEI-specific [19]. Here we build upon the
previously mentioned work in which we found CORT+CPO appears to be initiating a cell death
response via MAPK signaling, indicated by increases in p-JNK, and decreases in p-ERK1/2 and
p-MEK1/2. Similarly, DFP activates p-JNK, but CORT priming ameliorates this response. In the
present chapter, we report a subset of phosphoproteins are also activated in an AChEI-dependent
manner. p-BAD, p-RPS6, p-SRC, p-JNK, and p-SYK all displayed a significant interaction
between CORT and AChEI, indicating these phosphoproteins are key in differentiating between
all four exposures (DFP, CPO, CORT+DFP, CORT+CPO). Further, IPA analysis verified a
divergence of network signaling associated with each exposure by 2 and 24 h post-exposure.
Finally, TNF and IFN-γ were found to be crucial nodes for all networks, independent of time or
exposure linking to observed inflammation. Overall, this study found an array of inflammationactivated pathways that may provide insight into the very diverse symptomology observed with
GWI. Further investigation of the long-term effects of these signal transduction pathways should
be conducted to understand the interrelationship of neuroinflammation, acetylcholinesterase
inhibition, and phosphoprotein pathways in the disease progression of GWI.
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Chapter 6: Conclusions and Future Directions
There are several topics addressed within this dissertation with a focus on early signaling
that take place to protect and maintain optimal function within the body following exposure to
stressors. Further this dissertation displays systemic (Chapter 2) versus localized (Chapters 3-5)
responses, as well as different biological samples (saliva vs ex vivo tissue) to analyze various
biomarkers of stress. The knowledge obtained from this work provides an opportunity to enhance
our understanding of the biochemical adaptations that take place in response to both social and
occupational stressors in complex situations. The first study involves the complexity associated
with human work, especially those contributing to team dynamics, while the in vivo work provides
an insight into a more realistic mixture exposure that may occur in humans and further relates this
model to a potential disease state. Despite the information obtained from each of the studies, there
are limitations and future work that needs to be completed to further each project.
6.1 Salivary cytokines and social stress
Chapter 2 demonstrates that stressors can originate from social or physical situations and
can be measured systemically using noninvasive techniques. The ZephyrTM bioharness provides
real-time measurements of the physiological response experienced during the missions.
Importantly, saliva can be used as a biomonitoring technique to measure cytokine response. This
study, discussed in Chapter 2, provides a better understanding of social stress experienced during
a physical exercise, especially for military personnel in a naturalistic setting.
6.1.1 Sample size
As previously mentioned, a major limitation of this study involves the limited sample size.
Despite meeting statistical power, increased samples would provide more accurate averages and
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help determine any potential outliers that may be skewing the data. Furthermore, the subjects in
this study were a primarily homogenous samples in terms of age, body mass index, and gender
(Table 2.1). While homogenous samples do have advantages when focusing on a specific
demographic, these samples often fail to extrapolate the results to the general population.
Therefore, to further this work, potential differences observed among genders, socioeconomic,
groups, etc. should be included in future studies. Additionally, further investigations would expand
to include other teams (e.g., athletics) to further understand the cytokine responses in different
physical activity settings.
6.1.2 Order of missions
An additional limitation to highlight includes the order of the missions. Again, due to the
small sample size, we only performed the experiments in a single manner/order (baseline, success,
failure). To help further demonstrate the findings in the study are representative of cytokine
increases in response to failure, further studies should randomly assign the order of success and
failure between individual missions. Moreover, the team missions followed the individual
missions so it may be suggested the cytokine responses are not seen in the team missions because
the individuals were able to forecast what may be happening. Therefore, with an increased sample
size, future work should also randomly assign whether individuals complete the mission in a team
or as individuals first to address this question.
6.1.3 Correlation to blood
Another limitation to Chapter 2 involves the lack of correlation to blood cytokine levels.
Blood continues to be the standard diagnostic fluid, but there are limitations in the amount of blood
that can be drawn from an individual in a single day. In the present study, samples could only be
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drawn from the subjects before the baseline mission and after the failed mission. Therefore, the
current studied lacked the ability to perform statistical analysis to determine if blood cytokine
levels increased (or decreased) in response to success/failure or significantly correlated to the
salivary cytokines. Previous researchers have observed significant correlations between blood and
salivary biomarkers during both physical and psychological stress activities, but to further the
present work, future studies should be completed to determine if there are any significant
correlations to blood biomarkers.
6.2 Phosphoprotein signaling post-corticosterone and organophosphates exposure
Chapters 3-4 involve the localized spatiotemporal response to the combination of stress
(CORT) with occupational stressors (OPs) following a validated mouse model. It was determined
that CORT serves a partially protective role in phosphoprotein signaling post-exposure to DFP;
conversely, the combination of CORT with CPO ultimately enhanced pro-apoptotic activity. As
determined in Chapter 5, there was an array of inflammation-activated pathways that may provide
insight into the diverse symptomology observed with GWI.
6.2.1 Experimental time points
As timing is key in many studies, one limitation of these studies was the significant gap
between time points (2 to 24 h). Ideally, adding more time points would help provide additional
information that leads to the apoptotic nature observed for both DFP alone and CORT+CPO, but
accomplishing this can be difficult due to the large number of animals needed. Therefore, future
studies must expand on this time course to further understand the progression of the
phosphoprotein signaling. As this animal model also relates to the GWI disease state, it is crucial
to investigate the permanency of these altered signal transduction pathways. Additional studies
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will also further probe these proteins and their post-translational modifications at later time points
to better understand the long-term effects of these OPs.
6.2.2 Total protein
Another limitation of these studies was the lack of quantification of total protein expression
of proteins that were measured for phosphorylation. Without total protein expression
measurements of these phosphoproteins, it is unclear if the differences observed were due to
changes in the underlying protein content or their specific phosphorylation states. Since the time
course used in the present study is 24 h or less, it is expected that there would be little differences
in total protein concentration. However, to further validate the findings observed, future studies
would benefit from including a phosphoprotein to total ratio to help draw conclusions.
6.2.3 Brain region
The present studies examine several brain regions: the cortex and striatum postchlorpyrifos exposure, and the cortex and hippocampus post-diisopropyl fluorophosphate
exposure. These regions were chosen in order to relate previous findings involving cytokine and
acetylcholinesterase inhibition to the observed phosphoprotein signaling. The cortex plays a key
role in attention, perception, thought, language and voluntary action, while the hippocampus plays
a major role in learning and memory. The striatum is critical for the motor and reward systems
(e.g., decision making, motivation, reinforcement, etc.). Therefore, all of these brain regions play
into potential areas of focus for the symptoms associated with GWI. However, other regions of the
central nervous system could be crucial to get a complete understanding of the brain response to
these toxins. For example, future investigations of the cerebellum, which is involved in
coordinating voluntary movements and motor skills (e.g., balance, coordination, and posture),
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could help link the phosphoprotein signaling responses to additional GWI symptomology.
Additionally, while it is well established that the primary mode of action for these
organophosphates is the brain, it may be beneficial to observe other major organs, such as the liver
or kidneys, to determine the whole organismal response.
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APPENDIX A: Chapter 5 Supplemental

Table A.1. Proposed signaling nodes for a network generated by IPA at 0.5 h using the experimental dataset. The table
represents the nodes that were found to be different in at least one exposure.

DFP
ARID5A
CLEC6A
HCK
NKX3-1
CNR2
RASGRF1
LAT2
NCF4
PIK3R2

CPO
NCF4
ARID5A
CARD6
HCK
MAP3K2
SH2D2A
TOLLIP
CLEC6A
LAT2

CORT+DFP
CARD6
SH2D2A
TOLLIP
PLCB3
MAP3K2
NKX3-1
UBE2N
HCK
OTUD7B

CORT+CPO
CARD6
LRBA
NCF4
PIK3R2
CDH16
CLEC6A
NKX3-1
CNR2
IQGAP1

Table A.2. Proposed signaling nodes for a network generated by IPA at 2 h using the experimental dataset. The table
represents the nodes that were found to be different in at least one exposure.

DFP
CD79B
FCER1G
LAT2
PLG
ARID5A
CEACAM1
FCGR2A
LTB4R
NCF4
SELL
TREM2
CLEC6A
FCGR2B
HCK
RASGRF1
TYROBP
CD74
FGL2

CPO
CLEC6A
GPR19
IKBIP
MAP3K4
NQO2
RASGRF2
SH2D2A
TOLLIP
ATE1
LAT2
TRAFD1
CRK
HCK
PLCB3
UBE2N
CARD6
MAP3K2
RPS6KA3

CORT+DFP
ADCY5
BTG1
HCK
RASGRF2
RPS6KA4
GPR19
PLCB3
SH2D2A
TNFRSF18
ATE1
CRK
PPP2R1A
TRAFD1
EGR4
HAVCR2
MAP3K2
NFKBID
RPS6KA3

CORT+CPO
AKT3
BTG1
CRK
OTUD78
RPS6KA3
TOLLIP
CARD6
NCF4
RASGRF2
TRAFD1
ATE1
CLEC6A
GPR19
MAP3K2
PLCB3
UBE2N
NKX3-1
PPP2R1A
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Table A.3. Proposed signaling nodes for a network generated by IPA at 24 h using the experimental dataset. The table
represents the nodes that were found to be different in at least one exposure.

DFP
ARID5A
CEACAM1
FCGR2A
LTB4R
NCF4
CLEC6A
FCGR2B
HCK
RASGRF1
RPS6KA3
CD74
FGR
RASGRF2
SELL
TYROBP
CD79B
FCER1G
GPR19
LAT2
PLG

CPO
ALDH1L1
BTG1
CRK
RASGRF1
RPS6KA3
ARID5A
CD79B
FCER1G
HCK
RASGRF2
SH2D2A
TOLLIP
ATE1
CLEC6A
FGR
PPP2R1A
TRAFD1
GPR19
LAT2
NCF4

CORT+DFP
KITLG
PIK3CB
ROCK1
TSC1
BRAF
Foxp1
IL7
LRBA
PIK3CD
TSC2
CDH16
IQGAP1
NKX3-1
PIK3R2
VHL
HAVCR2
ITCH
S1PR1
CNR2
TNFSF10

CORT+CPO
ALDH1L1
CLEC6A
GPR19
LAT2
NQO2
RASGRF2
SH2D2A
ATE1
TRAFD1
CRK
HCK
MAP3K2
NCF4
PLCB3
UBE2N
CARD6
FGR
MAP3K4
RPS6KA3
TIRAP
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